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ABSTRACT 
 
In recent years new radiotherapy systems have emerged that are utilized for 
small tumour treatments with improvements to enable improved dose coverage 
of the target. The treatment is accurate but still would benefit from a real-time 
treatment monitoring with high spatial and temporal resolution sampling for 
regular quality assurance (QA). A monolithic silicon diode array, the Magic 
Plate 512 (MP512) was developed as a potential candidate for such QA. The 
detector was design for use as an in-phantom 2D dosimeter and 2D 
transmission mode detector for real-time dose measurements.  
The first part of this thesis evaluates the radiation response of the Magic Plate 
and the impact of an air gap immediately above the MP512. This air gap is then 
optimize for using the MP512 for small field dosimetry in both photon and 
electron fields. The output factor (OF), percentage depth dose (PDD) and 
enhanced dynamic wedge (EDW) beam profiles were measured as a part of 
these studies. The optimized air gap is then taken into account in the later 
chapters that focus on in-phantom dosimetry using the MP512. MP512 
response reduces with increasing air gap above the detector. The OF measured 
with MP512 with air gaps of 0.5 mm and 1.2 mm show a good agreement with 
OF measured with the EBT3 film (within ±2%) and MOSkin for 6 MV and 10 
MV, respectively. Similar results were observed for the PDD measurement. 
The EDW dose profile matched well with the EBT3 for the air gap of 0.5 mm 
within ±2% (1 standard deviation) for all wedge angles. The PDD measured by 
electron beams demonstrated no significant effect of the air gap size above 
MP512 for all energies.  
 
v 
The second part of this thesis demonstrates the use of MP512T as a 
transmission detector. The influence of operating the MP512T in transmission 
mode (TM) on the surface dose of a phantom was evaluated as a function of 
different field sizes and distances from the solid water phantom to transmission 
detector (Dsd). For all Dsd and all field sizes, the MP512T led to the surface 
dose increasing by between 5% and 25% when in the beam, depending on the 
configuration. The transmission factor of the MP512T ranged from 1.020 to 
0.9950 for all measured Dsd and field sizes.  
The last part of this thesis showed the correlation of transmission mode 
response (TM) and dose mode response (DM) of the Magic Plate512 
(MP512T) for different detector to surface distances (Dsd) and treatment field 
sizes. The measured correlation between TM and DM was then employed to 
predict the dose at dmax for regular fields, and intensity modulated fields. The 
calculated dose for regular fields of 1 x 1cm2 and 4 x 4cm2 fell in the range of 
[-2.18% and +1.95%] compared to the measured dose. For the calculated IMRT 
planar dose at dmax and gamma criteria of 3%/3mm and 2%/2mm pass rates of 
98.14%/90.5% and 97.22%/93.8% were found when compared to the dose 
predicted by the TPS for Dsd 4 and 24cm, respectively. Good agreement was 
also observed for these gamma criteria when comparing TM measurements 
taken at Dsd 4 and 24cm with EBT3 yielding pass rates of 96.89%/92% and 
97.53%/93.8%, respectively.  
The thesis therefore ultimately demonstrates that the dose in the phantom can 
be calculated based on TM measurements and these data represent the first step 
in the development of real-time high spatial resolution 3D dose reconstruction 
technique based on TM measurements from the MP512.  
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CHAPTER 1  
INTRODUCTION 
 
Any radiotherapy treatment aims to give a high radiation dose to the tumour but as low 
as possible to the surrounding healthy tissue. This aims to provide the maximum chance 
of curing or shrinking a cancer while minimizing the risk of side effects. Many studies 
demonstrate that such a high dose improves the outcome of tumour control, and a 
corresponding low dose reduces normal tissue toxicity [1]–[4]. Advanced radiation 
treatment techniques such as IMRT, VMAT, and SRS/SBRT have been used for 
delivering a high a conformal radiation dose to the cancer. These advanced radiotherapy 
techniques use a computer-controlled linear accelerator and typically consist of many 
intensity-modulated treatment fields which are incident from numerous different beam 
directions. Due to its complexity, high precision radiotherapy planning checks before any 
patient can start the treatment is required.  
The use of real-time dosimetry verification for a complicated treatment plans is 
recommended [5]. This verification aims to immediately detect errors that may occur 
during treatment delivery. High spatial resolution, real-time dosimetry devices are 
therefore needed due to the complex radiation fields that make up the treatment plan. 
The Centre for Medical Radiation Physics (CMRP) at the University of Wollongong has 
developed a two-dimensional monolithic silicon diode array called Magic Plate 512 
(MP512) with high spatial resolution. The detector is designed for use in both in-phantom 
dosimetry and transmission measurements. Both modes of operation of the MP512 will 
be characterized and optimized as part of the work presented in this thesis. 
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1.1 Thesis outline 
 
This thesis describes the use of the monolithic silicon diode array Magic Plate 512 for 
dose mode measurement and transmission mode measurements. Chapter 2 discusses the 
relevant literature related to the work presented in this thesis. Chapter 3 describes the 
design and fabrication of these two systems. Chapter 4 evaluates the impact of an air gap 
on the MP512 response and optimization of this gap for in-phantom dosimetry. The 
device is then characterized for its performance in small and standard treatment radiation 
fields. The optimized air gap size from this chapter is then used for in-phantom dose 
measurements in chapter 6. Chapter 5 investigates the effect on surface dose, as a function 
of different field sizes and distances from the solid water phantom to transmission 
detector (Dsd), of using the monolithic silicon detector MP512T in transmission mode. In 
addition, the transmission factor for the MP512T and the printed circuit board (PCB) were 
also evaluated. Chapter 6 investigates the correlation of transmission mode response 
(TM) and dose mode response (DM) of the MP512T for different detector to surface 
distances (Dsd) and treatment field sizes. The measured correlation between TM and DM 
was then employed to calculate the dose at dmax for regular fields. A clinical application 
using intensity modulated radiation fields was used to evaluate this correlation. Chapter 
7 presents the overall conclusions arising from the results and data found in studies 
presented in this thesis. The advantages, limitations and the future work of this device are 
also discussed. 
 
 
 
 
 
 
 
 
CHAPTER 2  
LITERATURE REVIEW 
 
 
This chapter aims to provide an introduction to some of the advanced radiation treatment 
techniques, including IMRT, VMAT, SRS and SBRT. An extensive background on the 
dosimeters for both pre-treatment verification, real-time treatment verification and small 
field dosimetry is presented.  
 
2.1 Radiation Therapy  
 
According to a study released by the World Health Organization (WHO), cancer is the 
leading cause of death worldwide with the incidence increasing at a rate of 2% each year 
from 2012-2017 [6], [7]. The three most used methods for this lethal disease treatment, 
include surgery, chemotherapy and radiotherapy. It is estimated that more than 50% of 
cancer patients would benefit from radiotherapy at some stage of their treatment course 
[8].  
Radiotherapy uses a high energy of ionising radiation to treat tumours. Ionizing radiation 
works by damaging the DNA of cancerous tissue leading to cellular death [9].  The beam 
can be delivered with various type of ionising particles such as electrons, photons (X-ray) 
,gamma (Gamma Knife) and protons [10]. Several methods are used to deliver radiation 
to the patient. External beam radiation therapy (EBRT) or teletherapy is the most common 
method of radiotherapy. EBRT uses a linear accelerator to generate high radiation dose 
delivery to a target from outside the patient body [11]. Other methods are internal 
Chapter 2: Literature Review 
 
4 
radiation therapy or brachytherapy where the radioactive source is introduced directly 
into a tumour [12], but this method is outside the scope of this thesis.  
EBRT aims to maximise the radiation dose to the cancer cells while sparing normal 
healthy tissue surrounded [13]. Some modern radiation treatment techniques have been 
developed to achieve the treatment goal, such as intensity modulated radiation therapy 
(IMRT), volumetric modulated radiation therapy (VMAT), stereotactic radiosurgery 
(SRS) and stereotactic body radiation therapy (SBRT).  
 
2.1.1 Intensity Modulated Radiotherapy (IMRT) 
 
IMRT delivers non-uniform radiation fluence to the target through various directions of 
the treatment beams from several gantry angles [14], [15]. With multiple beams, high 
doses can be delivered to the target volume, especially in the curvature shape and low 
dose to the critical organs [16].  To modulate the intensity of radiation, the change in the 
Multi-Leaf Collimator (MLC) position in the field is optimized by the inverse treatment 
planning system (TPS) based on advanced computing calculation [17], [18]. Inverse TPS 
for IMRT has been described in detail and can be found in the literature [19]–[22]. 
IMRT has two methods of treatment delivery including step and shoot technique and 
sliding window technique. With the step and shoot technique, the beam is on when the 
MLC are stable and allow multiple segments per field to be given. The beams stay still 
when the MLCs are changed from one segment to another. The sliding window technique 
keeps the beam on while the MLCs move through the irradiated field [23], [24].  
2.1.2 Volumetric Modulated Arc Therapy (VMAT) 
 
VMAT technique is developed from the IMRT technique. While IMRT delivers the 
radiation with static gantry, in VMAT the gantry is rotated around the patient for one or 
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more arcs continuously [25].  A number of parameters are varied during the treatment 
such as MLC shaping, dose rate, gantry speed and MLC orientation [26]. VMAT, in 
principle, is able to provide higher conformal dose compared to IMRT dose delivery 
because this technique uses all angles that are available in the inverse TPS to optimise the 
dose distribution [27]–[29]. The variation of gantry speed and dose rate enhances the 
significant advantage of VMAT and provides the shortest treatment time [30]. This 
reduces the effect of patient movement and intra-fraction motion in between radiation 
delivery. However, the physical constraints of the linear accelerator should be considered, 
such as maximum gantry speed, maximum leaf speed and the MLC orientation constraints 
[31]. Additionally, the angular dependence of dosimeter can be present, which must be 
corrected for verification technique [32]. Studies suggest the use of VMAT rather than 
IMRT for the complex treatment areas such as the head and neck region, prostate region 
and nasopharynges region [33]–[35]. 
 
2.1.3 Stereotactic radiosurgery (SRS) and stereotactic body radiation 
therapy (SBRT) 
 
SRS and SBRT have been used for more than ten years to eliminate benign and malignant 
lesions. The SRS had been developed to treat small brain tumours as well as functional 
abnormalities of the brain that could not be surgically removed [36]–[39]. These treatment 
techniques were initially developed to treat a small tumour which is usually less than 4 
cm [40]. SRS delivers in a single treatment of fraction but in SBRT the treatment dose 
delivered in a few focused radiation treatments, typically one to five fractions. These 
treatments lead to a shorter overall course of treatment time compared to other treatment 
techniques resulting in a reduction in radiation-related biological effects [41].  
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SRS and SBRT are complex due to the use of small field delivery techniques using IMRT 
or VMAT for SBRT employing either high definition MLCs and/or small circular cones 
in the case of SRS to fit a tumour [42]. This technique also optimises the gantry angle and 
weights with multiple isocentre or dynamically shaping the field during gantry rotation 
by mini or micro MLC [43], [44].  
The challenge for SRS and SBRT is to deliver accurately and precisely, high radiation 
dosage to a small area target and minimise the dose to normal tissue. Thus, a specialised 
planning and treatment delivery technique is needed.  The treatment planning verification 
is required to ensure that the patient will receive accurate and precise radiation treatment 
[45], [46].  
 
2.2 Quality Assurance (QA) and current QA tools 
 
2.2.1 Introduction  
 
The complexity of IMRT, VMAT and SRS/SBRT requires the precision of radiation 
delivery [47]. The treatment would not be effective if the tumour received a radiation 
dose less of than the prescribed dose. Additionally, the patient would develop radiation 
sickness if the normal healthy tissue and the vital organ received more than the radiation 
dose [48]. To ensure that the calculated radiation dose from the TPS is matched well with 
the dose delivered to the patient, the dose distribution needs to be accurately verified 
before, during or in between treatment fraction delivery [49]. Thus the treatment 
verification becomes an important part of radiotherapy to provide a safe radiation delivery 
and consistency in patient outcomes [50]. 
The treatment plan can be verified by transferring the patient plan to a phantom, measured 
using a dosimeter and compared with the calculated or predicted dose by the TPS at the 
Chapter 2: Literature Review 
 
7 
same points [51], [52]. The verification that mostly operates a day before the first 
treatment fraction in the absence of the patient is called pre-treatment verification. This 
procedure can detect some errors such as incorrect positioning of the MLC leaves; an 
incorrect plan exported from the TPS to the Linac; or any accidental changes occurring 
in the plan [53]. Thus, those errors can be corrected before the implementation of the 
clinical patient treatment plan. 
Various type of detectors have been used for pre-treatment verification; for example, there 
is point dose measurement systems such as ionisation chamber (IC), a semiconductor 
detector and metal-oxide semiconductor field-effect transistor (MOSFET) [54]–[57]. 
However, in a complex dose distribution, such as that used in advanced treatment 
technique, point dose measurements is unsuitable as it requires multiple measurement 
points for a treatment plan verification. A two-dimensional (2D) dosimetry techniques 
such as Film dosimetry, 2D array detectors have been produced for measuring energy 
fluence or absorbed dose in two dimensions [58], [59]. Additionally, to detect and 
measure the dose over the entire treatment volume, 3D detectors have been used to verify 
higher dimensionality measurements.  
Factors leading to errors which can occur during the whole treatment procedure in 
radiotherapy include patient miss positioning and a change in the patient’s anatomy due 
to weight loss or organ movement [60]. Additionally, the treatment parameters such as 
Linac setting and beam modifiers can be changed in between the pre-treatment 
verification, which has been reported by Huang et al. [61]. There is a considerable demand 
for real-time dose verification which enables real-time detection of major errors and can 
assess the dosimetric impact quantitatively during radiation delivery [62].  
Real-time verification can be carried out by using the transmission-type detector 
positioned in the photon beam between the Linac head and the patient or by means of 
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electronic portal imaging device (EPID) during the treatment. The commercial 
transmission detectors such as COMPASS system (IBA, Dosimetry), Dolphin system 
(IBA, Dosimetry) and David system (PTW-Freiburg, Germany) have been introduced for 
real-time dose verification.  
As mentioned above, the complexity of advanced treatment techniques with the use of 
small field dose delivery requires the careful selection of the suitable dose measurement. 
The ideal detector for radiation dose measurement should have the following 
characteristics: 
i) The detector should be tissue equivalent and not perturb the radiation beam. 
ii) The detector should have the small sensitive volume to avoid the volume 
averaging effect.  
iii) The detector should have a high dynamic range to manage with a large dose 
gradient that may be present per fraction of the treatment delivery. 
iv) The detector should have energy, dose rate, directional independence and dose 
response linearity [63]–[66]. 
In this section, a brief introduction of both pre-treatment QA tools and real time treatment 
verification tools is presented.  
2.2.2 Pre-treatment verification QA tools 
2.2.2.1 Point Dosimetry 
 
i) Ionisation chamber (IC) 
The ionisation chamber is widely used as an absolute point dosimeter [67]–[69]. The 
detector can have a wide range of physical shapes depending on the specific requirements, 
such as parallel plate chamber, concentrate cylindrical or a wire within cylindrical, 
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thimble chamber, condenser chamber, extrapolation chamber and waterproof chamber 
[13].  
The principle of this dosimeter is to measure an ion-pair generated by ionising radiation 
passing through the sensitive volume (gas cavity) of the detector. The ion-pair attach to 
either in the positive plate (anode) and a negative electrode (cathode) which connects to 
the battery to collect the signals. The diagram of an ionisation detector is shown in Figure 
2.1.  
 
 
Figure 2.1. The diagram of the ionisation chamber [70]. 
 
There are various operating regions of ionisation chambers depending on the voltage 
applied [71], [72]. For the normal ionisation region, the chamber operates when the 
amount of voltage is appropriated to collect all the ions produced in the active volume 
(100V-400V). However, it is insufficient to cause an increase in ion pairs due to gas 
amplification as the voltage increases [72]. The current read by the electrometer is 
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converted to the absorbed as the dose is proportional to the total ionising signal (charge) 
measured.  
A change in air density in the chamber may occur as a result of changes in temperature 
and pressure and may affect the reading as it will increase as the temperature increases or 
as the pressure increases [73]. Therefore, to convert the measured ionisation signal to the 
absorbed dose, a correction for temperature and pressure is needed [73]. The standard 
protocols such as TG-51 or TRS-398 outline the procedures that deal with this process 
[74], [75]. 
The ionisation chamber provides accurate and precise measurements and is recommended 
for beam calibration with essential corrections. More advantages of the ionisation 
chamber are its long-term stability, relative ease of use and instant direct read out [76]. 
However, the ion chamber indicates some volume averaging due to the detectors finite 
size of sensitive air volume [77], [78]. This effect limits the use of ion chambers where 
high dose gradients exist such as in complex treatment plans in IMRT, VMAT and 
SRS/SBRT. The chamber can overestimate the dose in certain circumstances due to its 
large volume [79]. Moreover, the under-response of the detector is presented in small 
fields due to the volume averaging and needs to be corrected [69].  
ii) Semiconductor detector  
A silicon diode is the most common semiconductor detector and also sometimes referred 
to as a solid-state ionisation chamber. It is widely used in radiation dosimetry for radiation 
protection, radiation imaging and radiotherapy dosimetry [76], [80]. The detector is 
produced by taking pure silicon and doping it with phosphorus to produce n-type or with 
boron to produce p-type material [81]. The n-type material semiconductor has a 
significant number of free electrons compared to intrinsic silicon. The n-type is 
electrically neutral due to the free electron positive donor ions. The p-type semiconductor 
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has a significant number of holes compared to intrinsic silicon. The p-type is electrically 
neutral due to the holes negative acceptor ions [82].  
Unlike the ionisation chamber, diodes can be operated without a bias applied [83]. A 
diode with an impurity of the opposite type is implanted into the surface region to create 
a p-n junction. The p-n junction alters the local electron and hole densities as well as 
creates the electrostatic potentials (built-in potential) in a diode close to the junction called 
the depletion region [84]. In this region, the free electrons will recombine with the hole, 
leading to diffusion of surplus charge carriers to the other material until thermal 
equilibrium is reached. At this point, the fermi level is equalised. The remaining ions 
create a space charge and an electric field stops further diffusion. 
When ionising radiation passes through the diode, electron hole-pairs will be produced. 
The free electron on p-type and the hole on n-type will diffuse toward the p-n junction 
[81]. By applying the external voltage (V), the charges produced in the diode are swept 
or drift across the depletion region under the action of the electric field and can be read 
by the electrometer [80]. The diagram of the p-n junction is shown in Figure 2.2. 
 
 
Figure 2.2. The diagram of p-n junction [85]. 
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The silicon detector shows high sensitivity compared to the ion chamber with the same 
active volume. This allows the diode to be designed with an extremely small sensitive 
volume giving rise to high spatial resolution measurements being able to be made [86]. 
Therefore, diodes are well suited to measuring in a high dose gradient region such as 
beam penumbra region. It also provides for excellent charge carrier collection because of 
high mobility and a long mean free path of the majority and minority charge carriers [87].  
However, on the negative side, the occasional recalibration for diodes is necessary as they 
suffer radiation response degradation due to radiation damage. The sensitivity of the diode 
decreases with accumulated dose with both p-type and n-type diodes [88]. The radiation 
response of the diode is also dependent upon temperature which should be taken into 
account. Grusel et al. found that the diode signal is increased by about 1-3% per 10 °C 
change in temperature [89].  
Moreover, diodes yield over response to low energy photons ranging from 10 keV to 200 
keV due to the high atomic number (Z=14) of the silicon relative to tissue (water). This 
leads to an increased photoelectric effect in this energy range compared to water where 
the Z is about 7 [68], [80]. 
iii) MOSFET Dosimeter 
The principle of the radiation sensitivity of a Metal-Oxide-Semiconductor Field Effect 
Transistor (MOSFET) is based on the creation of ‘electron-hole (e-h)’ pairs similar to the 
semiconductor detector. However, the relevant e-h pairs, when a MOSFET is used as a 
dosimeter, are generated in the gate oxide. MOSFETs were first utilised for radiation 
dosimetry by Andrew Holmes Siedle et al. in 1978 [90], and they have been used in 
radiotherapy for decades [90]–[92]. 
When ionizing radiation passes through the silicon oxide layer (SiO2), the positive 
charges drift under the electric field (if applied) and accumulate via traps at the Si-SiO2 
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interface. The accumulation of these charges influences the current flow between the 
source and the drain of the MOSFET for a given applied bias [93]. In a constant source-
drain current configuration the difference between the threshold voltage measured under 
the constant current, before and after radiation exposure, is a function of the absorbed 
dose in SiO2 [94]. 
The MOSFET is small, and the gate oxide is very thin, providing the possibility of the 
shallow dose measurement. Many papers discuss the use of MOSFET for surface dose 
measurement as an in-vivo radiation dosimeter [95]–[99]. The MOSFET is not dose-rate 
independent but does offer real-time readout. As the radiation sensitive property of the 
MOSFET is of an integrating nature, the detector total dose history can be stored [93].  
Similar to other semiconductor detectors, the MOSFET has temperature dependence and 
a limited lifespan that should be taking into account with regular recalibration necessary 
[76], [96]. 
 
2.2.2.2 Two-Dimensional (2D) dosimetry 
i)  Film dosimeters 
The traditional radiographic film consists of a base of thin plastic with a radiation 
sensitive emulsion, silver bromide (AgBr) crystal, coated on one or both sides of the film 
[100]. The interaction of radiation to the AgBr forms the latent image in the film. When 
the film is developed, the small grains of metallic silver is reduced making the film 
opaque [101]. This opacity is defined in terms of the optical density (OD) which is a 
function of radiation dose exposed to the film [102]. The radiographic film has an 
excellent spatial resolution (<1mm) and can be cut into various shapes of the different 
area [102]. The development of an extended dose range (EDR) film allows radiographic 
film to be used over a wider dose range than traditional films [103]. However, the 
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requirement of chemical processing to develop or fix the image and the requirement of 
darkroom facilities is leading to the decreasing usage of the radiographic film [104], 
[105]. 
The self-developed film has been introduced by David Lewis and is referred to as 
radiochromic film [106]. Unlike radiographic film, radiochromic film is self-processing, 
eliminating the wet chemical processing step [107]. This film consists of a single or 
double layer of radiation-sensitive organic microcrystal monomers, on a thin polyester 
base with a transparent coating. This radiation sensitive monomer is polymerised by a 
topochemical (solid state) process to form the film opacity without any latent image [108]. 
The radiochromic film material is close to tissue equivalent when compared to 
radiographic films, and it can be measured in various ranges of high radiation dose (1-10 
Gy) [107]. Thus, radiochromic film has been shown to be used as a QA tools in clinical 
dosimetry [109]–[112].  
The film is a high spatial resolution, large sensitive area QA tool. It provides a 2D 
intensity map from a single exposure which can be converted to the 2D dose mapping by 
using the calibration curve [110]. However, the film dosimetry is not generally used for 
real-time measurement because the film developing takes around 24-48 hours to stabilise 
the film response [106]. Additionally, the film response depends on many factors 
including; the film plane orientation, densitometer/digitiser artefacts, temperature, 
humidity and storage conditions [106], [113]–[116].  
 
ii)  2D Ionisation chamber array 
The PTW 2D ARRAY developed by PTW-Freiburg Germany is an example of 2D 
ionisation array. The ARRAYS are available in two versions that provide different 
numbers and sizes of ionisation chambers. Version 1 consist of 256 ion chamber arranged 
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in a 16 x 16 matrix while Version 2 consists of 729 ion chamber in a 27 x 27 cm2 matrix. 
Both versions cover the area of 27 x 27 cm2. The basic characteristic were studied by 
Poppe et al. The detector demonstrates both short-term and long-term reproducibility 
within 0.2% and 1%, respectively [117]. Poppe et al. examined the use of PTW 2D 
ARRAY for IMRT verification. The plan was verified by placing the detector 
perpendicular to the Linac gantry which was set to a 0-degree delivery [117], [118].  
Another example of 2D ionisation chamber array is MatriXX (IBA dosimetry, 
Scanditronix Wellhofer GmbH, Germany). This detector consists of 1024 ion chamber in 
an active area of 24 x 24 cm2. The detector diameter is 4.5 mm with 7.62 mm to each 
adjacent detector distance. Each detector has a sensitive volume of 0.08 cc. Yan et al. 
reported that the detector has good dose linearity and provides stable long-term 
reproducibility with respect to low dose rate dependence [119]. Wolfsberger et al. 
characterised the angular dependency of MatriXX and found the discrepancies in detector 
response (up to 11%) as a function of gantry angle (Anterior-Posterior VS Posterior-
Anterior fields). This effect is due to air-high-Z material interfaces [120]. Han et al. 
examined this detector for IMRT QA and found that the detector was successfully used 
for IMRT QA, but the issues of the detector volume averaging effect were reported [121]. 
 
iii) 2D silicon diode array 
MapCHECK (Sun Nuclear, Melbourne, USA) consisted of 445 N-type silicon diodes and 
covered the active area of 22 x 22 cm2. The active volume of the detector is 0.8 x 0.8 mm. 
MapCHECK separates into two areas; the outer band array has 2.0 cm horizontal and 
vertical spacing. The inner band array with the area of 10 x 10 cm2 has 1.0 cm horizontal 
and vertical spacing [122]. The detector response presents excellent dose linearity. 
However, the N-type diodes have a temperature coefficient of 0.54%/°C. Thus, the 
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detector storage at or close to the treatment room temperature is recommended [59]. As 
a silicon diode detector, MapCHECK degrades as they accumulate dose. So, it is 
necessary to check and update the array calibration annually regularly or as needed [123]. 
Several studies examined MapCHECK for IMRT and VMAT pre-treatment verification 
[33], [124]–[126]. Liu et al. found that the detector presented inconsistency with a gamma 
comparison (3%/3mm) and that this deviation increased when the IMRT plan is more 
complex [119]. This might be due to the few sampling points within the field, especially 
for small fields and the detector resolution influenced by the non-uniform detector 
distribution spacing of between 7 mm and 14 mm. 
 
2.2.2.2 Three-Dimensional (3D) dosimetry 
 
Advanced radiotherapy typically delivers a dynamic radiation beam with the dose rate, 
MLC geometry, and gantry angle continuously varying. The 2D dosimeter mentioned 
above is often used to validate a treatment in a single planar dose distribution. To provide 
the information in full 3D dose distribution throughout the entire treatment volume, 3D 
dosimetry is required. 
i)  ArcCHECK 
ArcCHECK (Sun Nuclear, Melbourne, USA) is an example of a 3D dosimeter. The 
detector consists of 1386 N-type diodes in a cylindrical phantom. This system was 
developed for the rotational therapy QA. The diode air embedded with 10 mm spacing in 
a spiral pattern to increase the spatial sampling rate. The cylindrical phantom is 21 cm in 
diameter and length. The active volume of the detector is 0.8 x 0.8 mm. The detector 
spacing is 1cm x 1cm, and smaller when projected at the different source to surface 
distance (SSD). The basic characteristics of ArcCHECK were studied by Li et al [127]. 
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The detector showed the good response for short-term and long-term reproducibility, dose 
rate dependence, dose linearity, dose per pulse dependence. Nevertheless, ArcCHECK 
presented directional dependence. At the gantry 105°, the directional dependence was 
varied about 9.1%[127]. ArcCHECK has been reported to be used for IMRT and VMAT 
QA [128], [129].  
ii) Gel dosimetry 
Gel dosimetry was first introduced in 1950 by Stein et al [130]. At that time, they studied 
the colour changes in the gel containing dyes produced by radiation in aqueous solution. 
The chemical change related to the absorption of radiation dose.  
More recently, the dosimeter polymer gel is made from various agents which are sensitive 
to radiation such as gelatine, agarose, Sephadex and polyvinyl alcohol [131], [132]. Gels 
are nearly tissue equivalent. Thus, no energy correction is required for both photon and 
electron beams. It can be modelled to any desired shape and have high spatial resolution. 
The dose distribution was recorded in three-dimensions and can be read out by several 
methods such as magnetic resonance imaging (MRI), computed tomography (CT) or 
ultrasound technique [133]–[135].  
Gel dosimetry became one choice of radiation dosimetry. It was previously used for 
IMRT, VMAT, SRS and SBRT dose measurement [136]–[138]. The disadvantage of gel 
dosimetry is that it’s processing is complicated and expensive.  Reproducing the gels with 
similar radiation sensitivity is difficult.  The use of this dosimetry for routine radiation 
measurement is limited [139]. 
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2.2.3 Real-time treatment verification QA tools 
 
2.2.3.1 Amorphous Silicon Electronic Portal Imaging Device (EPID) 
The EPID system consists of a flat panel array mounted on a retractable arm opposite the 
Linac beam. It was primarily designed for daily imaging to verify the geometric accuracy 
of radiation filed on the patient [140].  
The new generation of EPID system is the amorphous silicon-based system. The EPID 
system has been extended for the purpose of dosimetric verification related to image 
information. There are several ways to use EPID as a dosimetry QA tool. One method is 
to use the device to verify the MLC position by capturing a series of snapshot images 
during a dynamic MLC prescription. This method can be operated both online and off-
line [141], [142]. Another method is to reconstruct the radiation dose to the patient by 
using the exit images acquired by the system during the treatment [143]. This method 
requires some corrections from the scattering of the build-up material [144]. The recently 
used method is to convert EPID image to an incident fluence distribution and use as the 
input to compute the dose to the patient by the back projection method [145].  
The characteristics of EPIDs have been reported and mention that the response of an EPID 
is linear with integrated dose and not dependent on dose rate [146], [147]. It is non-tissue 
equivalent material and over sensitive to low energy photon beam.  Image contrast with 
high photon energy (MV) is lower than with kV beam used in diagnostic radiography 
[148]. Thus, for the purpose of patient setup, the patient image is performed with the kV 
source incorporated with the Linac gantry, e.g. Varian OBI system [149]. 
EPID has been used for IMRT plan verification with advantages over the traditional use 
of films such as ease of use, real-time imaging display and instant comparison with TPS 
[150], [151]. However, the procedure to convert the image to the dose is complex and it 
is still a challenge for VMAT verification because of the dose rate changes continuously 
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[152]–[154]. This leads to a phase shift between MLC leaf openings and the portal arc 
[155].  
 
2.2.3.2 DAVID System 
DAVID system (PTW-Freiburg, Germany) is a transmission-type detector which has 
been developed for only a standard Siemens Linac (Siemens Healthcare Pty Ltd, 
Germany). The detector consists of a flat, vented translucent multi-wire ionisation 
chamber [156]. The number of IC is equal to the number of MLC leaf pair of the Linac 
machine. The device can be placed at the wedges or block tray slot or can be permanently 
installed at the Linac head, which is only used for IMRT. The distance from one detection 
wire to the next one is 4.31 mm [156]. Each wire of DAVID system corresponds to the 
MLC leaf-pair to verify the movement of the leaf during IMRT treatment. The measured 
signal of all wire is a dose area product of the transmitted photon beam and the total 
radiation dose to the patient [156]. The influence of the detector, when used in 
transmission measurements, has been reported by Poppe et al [157]. They reported that 
there is radiation absorption by the chamber due to the tray factor and there is surface 
dose perturbation especially at small field sizes. Karagoz et al [158] investigated the 
David system for IMRT QA. They found that the deviations in leaf position of static 
IMRT plan were within 3% from the first week of treatment with a strong correlation with 
EPID. The deviation of leaf position is dependent on the intensity level. 
 
2.2.3.3 Delta4 AT Discover  
Delta4 AT (Scandidos AB, Uppsala, Sweden) consists of 4,040 p-type diode detectors. 
The detectors have an active area of 1 mm in diameter [159]. The active detector covers 
an area of 25 x 20 cm2 when the beam is projected to a distance of 100 cm source to axis 
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distance. The device has various detector spacing, depending on the axis direction, e.g. 
along the MLC leaf in X direction the detector spacing is 1.6 mm apart while in Y 
direction space is 3.2 mm intervals. The overall detector thickness is 4.0 cm when placed 
at 63.6 cm source to device distance [160].  
This device is an additional component to a Delta4 PT (Scandidos AB, Uppsala, Sweden) 
[161] which provides the pre-treatment QA data. Both systems share software to be used 
during patient treatment. The patient pre-treatment QA data is used to calculate the virtual 
dose based on the Delta4 AT measured data by the QA software [160]. The interval time 
for transferring the Delta4 AT measured data to the software is 25 ms. The beam 
perturbation when the device was in the beam path was evaluated. The surface dose 
increase varies from 1% - 9% depending on photon energy and radiation field size [160]. 
The largest change in the percentage depth dose (PDD) measurement was observed at a 
depth of 10 cm with 0.5% decrease in dose [160]. 
 
2.2.3.4 COMPASS  
COMPASS (IBA Dosimetry, Germany) is a pixel segment 2D ionisation chamber array. 
The array consists of 1600 air vented plane-parallel ion chambers. The detector’s active 
volume is 0.02 cm3 in the active area of 40 x 40 cm2.The detector spacing is 6.5 mm 
COMPASS can be attached to the Linac head (Varian Linac 2100iX). The source to 
detector distance is 65 cm. Sankar et al. studied the influence of the COMPASS system 
when used in the transmission mode for 6 MV photon beams. They found an increase in 
the surface dose for shorter SSD and the large irradiated field. Beyond the depth of 
maximum dose, the perturbation properties were in good agreement with the open field 
[162]. 
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2.2.3.5 Dolphin dosimetry system 
Dolphin dosimetry system (IBA Dosimetry, Germany) consists of 1513 air-vented plane-
parallel ionisation chambers. The active area is 24 x 24 cm2. Each chamber has a diameter 
of 3.2 mm and 2 mm height. The pixel pitch is 5 mm in the inner detector area and 
approximately 8 mm in the outer area with the active volume of 0.016 cm3 [163]. The 
device corresponds to the COMPASS dosimetry software (IBA Dosimetry, Germany) 
[163]. The surface dose increasing when the Dolphin detector was in the beam was found 
the maximum about 11% at the SSD of 80 cm [164]. The influence on PDD measured by 
dolphin detector was 1% beyond the depth of maximum [164]. Thoelking et al. evaluated 
the clinical performance of this system and found that a good agreement for dose 
reconstruction based on dolphin detector read-out compared to TPS  was observed for 
IMRT plans with a 3% error of MLC position [165]. 
 
2.2.3.6 The Integral Quality Monitoring system (IQM)  
IQM system consists of an area integrating energy fluence monitoring sensor (AIMS) and 
a calculation module (IQM_CALC). This detector is designed to be mounted with the 
final beam shaping device, the MLC and the patient. The detector is made from 
Aluminum and has a physical size of 22 x 22 cm2. The detector sensitive volume is 
530 cm3 and can monitor the maximum radiation field size of 34 x 34 cm2 at the isocentre. 
The principle of this system is that the dose measured by AIMS will be compared with 
the predicted dose calculated by IQM_CALC.  The signal from the ion chamber (AIMS) 
provides spatially dependent dose-area-product for each beam segment. The calculation 
dose (from IQM_CALC) is based on the integration method associated with the 
information from the TPS. The signals from AIMS and IQM_CALC are compared in 
real-time. Islan et al. studied the IQM system and found that the chamber attenuates the 
Chapter 2: Literature Review 
 
22 
beam intensity by 7% and 5% for 6 and 18 MV beams, respectively, without changing 
depth dose, surface dose and dose profile characteristic for field size 10 x 10cm2 [166]. 
Although some transmission QA dosimetry devices are available, the spatial resolution 
and beam perturbation for some of them make their use in  clinical practice for the 
advanced treatment technique such as SRS and SBRT for real time treatment verification, 
questionable.  
 
2.3 Center for Medical Radiation Physics (CMRP) semiconductor 
dosimetry 
 
Many devices have been developed for the purpose of advanced treatment technique QA 
such as SRS and SBRT as mentioned previously. Due to the complexity of the SRS and 
SBRT delivery with a very small field, there is a considerable demand for real-time dose 
delivery verification with high-resolution detectors during patient treatment. 
Center for Medical Radiation Physics (CMRP), University of Wollongong developed the 
2D diode array Magic Plate 121 (MP121) as an online radiation detector. The detector is 
based on small single epi-diodes embedded in a KAPTON carrier with pitch 1 cm and 
overall thickness of 0.45 mm only. MP121 has been used as a transmission detector for 
real-time dose monitoring in which the detector was mounted on the Linac head. The 
detector presented minimal beam perturbation leading to an increase in the surface dose 
of less than 0.5% [167]. However, the spatial resolution of the MP121 detector is 
precluding its effectiveness for small field real-time QA. 
A new detector, the Magic Plate 512 (MP512), has been developed with a better spatial 
resolution. MP512 is a silicon monolithic with a low resistivity p-type substrate. The 
detector consists of 512 pixels with a 2 mm detector pitch. The silicon detector arrays 
with thickness 0.45 mm are wire bonded to a thin 0.5 mm tissue equivalent printed circuit 
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board (PCB) and covered with a layer of resin to protect it from any accidental damage. 
The use of MP512 in in-phantom dosimetry has been previously studied [168], [169].  
Additional studies for in-phantom dosimetry of MP512 will be presented in Chapter 4. 
The dose mode measurements such as output factor, percentage depth dose and beam 
profile with different air gap size above the detector will be evaluated with various field 
sizes (include small field size) for both photon beams and electron beams. The following 
chapters (chapter 5, chapter 6 and chapter 7) present the use of a thin transmission 
monolithic MP512 detector as a transmission QA tool.  
 
2.4 Small field dosimetry 
 
Advanced radiation treatment techniques such as SRS and SBRT traditionally use small 
radiation fields in sub centimetre range to treat tumours and spare normal tissue. 
IAEA/AAPM define a small field as a field where the dimension is smaller than the lateral 
range of the charged particles. Generally, the small field is defined as a filed size of less 
than 4 x 4 cm2 [170]. There are three existence conditions represented in small filed 
dosimetry and are discussed below. 
2.4.1 A loss of lateral charge particle equilibrium (LCPE). 
 
LCPE is a part of charge particle equilibrium (CPE) associated with a range of secondary 
electrons [171]. CPE effect can be explained by the Bragg Gray cavity theory. In this 
theory ionisation chamber (IC) is used as a reference detector and assumes that it does 
not disturb the particle fluence when inserted into a medium [172]. The CPE exists for 
volume v when the energy absorbed per unit mass equals the energy imparted per unit 
mass [171]. This means the ionisation produced within the gas-filled cavity inside the 
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medium is proportional to the energy absorbed. Therefore, absorbed dose (D) equals total 
kerma of primary radiation photon (ratio =1). 
 
𝐷
𝐾𝑐𝑜𝑙𝑙
= 1 
In a photon beam the kerma is defined as the initial kinetic energy of all charged particles, 
mainly electrons and positrons, liberated by photon interactions per unit mass in a 
medium. Since part of this kinetic energy may be converted back to energetic photons 
mainly through bremsstrahlung and annihilation in flight processes it is useful to analyses 
that part to the kerma which remains as kinetic energy of charged particles, namely the 
collision kerma, kcol [173], [174]. 
When the field size decreases, the variation of electron fluence depends on the radiation 
field size [175]. The maximum of secondary electrons range is larger than the closest filed 
edge. This causes an uncertainty of the dose in the small field compared to the calibration 
filed where Bragg Gray cavity is broken down, and lateral charge particle disequilibrium 
occurs [176].  
Another concept of CPE was explained by Das et at. They stated that the beam is broad 
and parallel. Thus, there exists an artificial source everywhere to compensate for any 
photon loss during interaction [177]. LCPE is used for nonstandard beam and is used for 
an infinite flat, broad beam and homogeneous phantom where the photon fluence is 
laterally uniform at all depths and in all directions for all energies [178]. The loss of 
scattered photons for each primary photon is replaced by scattered photons which is 
generated by other primary photons in the beam direction. If the medium is changed, the 
number of photons and scattered photons generated laterally depend on the properties of 
the medium such as medium density. So LCPE can no longer be existed [179]. In a small 
field, a lack of LCPE is considered when radiation direction passes through an 
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inhomogeneous medium including the detector. Hence the correction for beam 
perturbation in an inhomogeneous medium is needed for the detector [177], [179]. 
 
2.4.2 Partial source occlusion 
 
The photon fluence from the Linac machine consists of primary photons and secondary 
photons. The former generates directly from the target focal spot while the latter is 
produced from the structure of Linac head as the scattered photons [180]. Generally, the 
target is spread over the area, and the source profile size is determined by full width at 
half maximum (FWHM) [13]. The beam size is collimated by the collimators. By 
decreasing the collimator setting, the field size decreases. The primary photon and 
scattering photon is blocked by the collimator leading to a reduction in the absorbed dose. 
Moreover, the FWHM of the source profile is reduced when decreasing the collimator 
setting [181]. Thus, the small field size output is lower than the field size at which the 
whole source can be seen from the detector point of view as shown in Figure 2.3. 
 [177], [178], [182].  
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        (a)                                  (b) 
 
Figure 2.3. (a) Broad beam and (b) small beam from the detector point of view. 
 
 
2.4.3 The detector volume averaging effect 
 
The radiation dose measured by a dosimeter is associated with the averaging charge over 
the entire sensitive volume of the detector, where the dose is proportional to a number of 
charged particles [183]. To measure the accurate dose, the detector should be irradiated 
uniformly. In a small field, a steep dose gradient can be affected by the dosimeter which 
has a large sensitive volume compared to the radiation field size. A flat field profile 
includes a portion of penumbra might be measured over the sensitive volume [178]. The 
measured dose would not be accurate and may result in reduced signal [78].  
The dose calculation for treatment planning requires beam data to drive the calculation 
model such as output factors [184]. When measuring the output factor for SRS/SBRT 
field (small field) with a large dosimeter, an underestimation of the output factor will be 
present in the measurement. The incorrect beam parameter for dose calculation would 
cause the miscalculation which significantly affects the treatment [185], [186]. So the 
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high spatial resolution dosimeter with a small active volume and good reliability which 
minimise the volume averaging effect is important for small field dosimetry [178].   
 
2.5 Skin and surface dose 
 
The International Commission on Radiation Units and Measurements (ICRU) and the 
International Commission on Radiological Protection (ICRP) recommend the skin depth 
for practical dose assessment should be at a depth of 0.07 mm below the surface. This 
depth is the deepest layer of the epidermis and lies above the basement of the membrane 
and is also known as the basal layer [187]–[191]. 
Many studies have shown that in radiotherapy, the skin dose is affected by changing in 
parameters such as patient geometry, beam energy, SSD, field size, the use of wedges, 
blocks, block trays, thermoplastic mask and bolus [192], [193]. 
Yadav et al., estimated the skin dose for various beam modifiers and SSD for 6 MV 
photon beams. They found that skin doses were increased as the SSD decreased and were 
dominant for larger field sizes. The measured skin dose due to a motorised 60° wedge for 
the 10 x 10 cm2 field was 9.9%, 9.5%, and 9.5% at 80 cm, 100 cm and 120 cm SSDs. The 
measured skin dose due to acrylic block tray, of thickness 1.0 cm for a 10 × 10 cm2 field 
was 27.0%, 17.2% and 16.1% at 80, 100 and 120 cm SSD, respectively [194].  
Doracy et al. have measured 79% of the maximum dose when treating through the 
material versus 22% of the maximum dose when no beam modifier or immobilisation 
devices are used [193]. 
Kim et al. confirmed that the skin dose increased as the field size increased. They showed 
that for all field sizes the skin dose increased with the use of block tray; 7% to 59% for 8 
MV and 5% to 62% for 18 MV beam [195]. 
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Several radiation detectors have been used to investigate the surface dose and build up 
regions such as a parallel-plate ion chamber, TLD, film and MOSFET. Each detector has 
its own advantages and disadvantages that may make it more favourable than the others 
in the various applications. 
TLD can be used for in vivo dosimetry because of its low cost and tissue equivalent. The 
extrapolation method is used for TLD skin dose measurement. However, it cannot read 
in real-time due to the complexities of TLD processing [196]. Film dosimetry has been 
used for surface dose measurement due to the  effective film depth being near the basal 
layer and its high spatial resolution. So it is not necessary for any correction unlike the 
dose measured by the ion chamber [197]. However, film dosimetry is time-consuming 
and the signal can be affected by many parameters which have been discussed previously 
in 2.2.2.2 [198]. Rosenfeld et al. promoted MOSFET for surface dose measurement. The 
MOSFET data showed excellent agreement with the reference chamber (Attix ion 
chamber) in the build-up region. It is small in size and has a simple reading circuit which 
can be read out online [92], [93]. 
 
2.6 Gamma evaluation 
 
The gamma evaluation method as presented by Low et al. [51] is designed to compare the 
measured dose distribution and the calculated dose distribution. Figure 2.4 shows a 
diagram of the gamma evaluation method. This figure is presented for a single 
measurement point. Generally, all measurement points are repeated for the comparison in 
the clinical practice. The measured dose (rm) is used as reference information, and the 
calculated dose (rc) is queried for comparison. X and Y axes are the spatial locations of rc 
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and the Γ axis represents the difference between the measured dose [Dm (rm)] and 
calculated dose [Dc (rc)]. 
 
Figure 2.4. A diagram of the gamma evaluation method [51]. 
The acceptance criteria are defined by ∆DM for the dose difference and ∆dM for the 
distance to agreement. The acceptance criteria is an ellipsoid defined by 
 
1 =  √
∆𝑟2
∆𝑑𝑀
2 +
∆𝐷2
∆𝐷𝑀
2  
 
where ∆r is the distance between the reference and compared point 
 
∆r = │rm - rc│ 
 
and ∆D is the dose difference between dose distribution at rm (Dm) and rc (Dc), Thus 
 
∆D = Dc(rc)-Dm(rm) 
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A quantitative measure of the accuracy of the correspondence is determined by the point 
with the smallest deviation from the reference point lying within the ellipsoid of 
acceptance, i.e. one point for which: 
 
𝛤𝑚(𝑟𝑐, 𝐷𝑐) = √
∆𝑟2
∆𝑑𝑀
2 +
∆𝐷2
∆𝐷𝑀
2  ≤ 1  
 
The pass and fail criterion therefore become 
Γ(rm) ≤ 1, correspondence is within the specified acceptance criteria. 
Γ(rm) > 1, correspondence is not within specified acceptance criteria. 
An implicit assumption is made that once the passing criteria are selected, the dose 
difference and DTA analyses have equivalent significance when determining calculation 
quality.  
 
 
  
 
 
 
 
CHAPTER 3  
METHODOLOGY 
 
In the previous chapter, the QA tools for advanced treatment techniques for both pre-
treatment and real-time treatment were reviewed. The development of a new silicon diode 
detector array ‘MP512’ was introduced as a QA system. This chapter describes the Magic 
Plate 512 detector system that was used in this thesis for in-phantom dosimetry and 
transmission dosimetry. The electronic readout system will be described as well as other 
detectors that have often been used to compare with the MP512 dose response.  
 
3.1 Linear accelerator and field arrangement 
 
For the work described in this thesis, the photon beams and electron beams were 
generated by a linear accelerator Varian model 2100IX (Varian Medical Systems, Palo 
Alto, CA). All experiments were performed at the Illawarra Cancer Care Centre, 
Wollongong Hospital, Wollongong. 
The Linac provides dose rates of between 100 MU/min and 600 MU/min with 100 
MU/min increments. The maximum MU that can be delivered is 9999 MU for any one 
treatment. The field size in this study is defined at the 100 cm SSD. The field sizes are 
collimated by the Linac jaw and MLCs and varied from 1 x 1 cm2 to 20 x 20 cm2. 
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3.2 Magic Plate 512 
 
The Magic Plate 512 (MP512) was designed and developed at the CMRP. It is a 2D array 
of isolated p-i-n silicon diodes embedded together in an ion-implanted silicon monolithic 
diode detector, manufactured on a bulk p-type substrate. The silicon substrate is 0.45 mm 
thick. The MP512 array consists of 512 pixels with a detector array-element size of 0.5 x 
0.5 mm2 and pitch 2 mm with an overall dimension of 52 x 52 mm2 as shown in Figure 
3.1. The MP512 monolithic detector is mounted and wire bonded to a printed circuit board 
(PCB) 0.5 cm thick and covered by a thin layer of resin to preserve the silicon detector 
from moisture and chemical contamination and to protect the wire bonds [168]. 
 
 
Figure 3.1. Magic Plate 512 bounded with the PCB  
 
The PCB provides the fan-out for connecting the sensor to the readout electronic system. 
The MP512 detectors operate in passive mode and have no bias voltage applied to the 
diodes. In this thesis, a thin monolithic silicon detector MP512 was designed to operate 
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in both dose mode measurement (in-phantom) and transmission mode measurement 
arrangements.  
3.2.1 Magic Plate 512 for in-phantom measurement 
 
To use the detector for in-phantom dosimetry, the MP512 was placed between two 
polymethyl methacrylate (PMMA) slabs to protect the detector from mechanical damage 
and shielding the sensor from ambient light [199]. Figure 3.2 presents the MP512 and the 
schematic diagram of MP512 embedded for in-phantom measurement. Some 
characterisation of MP512 and the use of detector as an in-phantom QA tool has been 
previously reported [168]. In this thesis work, the characterisation is extended 
significantly as it focused on operating the device in transmission mode.  In chapter 4, 
more details of the detector characteristics will be studied such as the effect of the air gap 
on detector response and the optimisation of the suitable air gap size upstream of the 
silicon detector. 
 
 
(a) 
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(b) 
 
 
(c) 
 
Figure 3.2. (a) MP512 detector wire bonded to the PCB sandwiched with the two 
PMMA slabs, (b) MP512 when used in dose mode in phantom dosimetry and (c) a 
schematic diagram of the MP512 packaged between two PMMA slabs. 
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3.2.2 Magic Plate 512 for transmission mode measurement   
 
To use MP512 as a transmission detector, the detector is embedded with different 
packaging. The detector is sandwiched between 3 mm thick PMMA sheets with an 
opening area of 9.5 x 9.5 cm2 at the centre of the board in both front and back of the 
detector to generate a 0.45 mm thick transmission detector.  
When operating the MP512T in transmission measurement mode, the detector is covered 
with a black plastic sheet (80 µm), to reduce light leakage to the detector. The MP512T 
is placed on a movable stand holder which has the capability of moving in a vertical 
direction. Moving the detector along the beam axis between the patient surface and the 
Linac head enables the detector to change the effective spatial resolution that the radiation 
field is sampled. The concept of a movable transmission high-resolution detector and 
more details will be explained in chapter 5. Figure 3.3 shows the MP512T when used in 
transmission dosimetry and the detector packaging schematic.   
 
 
 
 
 
 
 
 
 
 
(a) 
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(b) 
 
 
 
 
(c) 
Figure 3.3. (a) MP512T detector wire bonded to the PCB and sandwiched with the two 
PMMA slabs with the opening in place of the detector, (b) MP512T placed on the 
movable stand holder when used in transmission mode measurement (c) A simplified 
schematic of MP512T packaging 
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3.3 The data acquisition system (DAQ) 
 
The MP512 data acquisition system was custom designed at the CMRP. The system is 
based on a multichannel electrometer chip named AFE0064 from Texas Instruments. The 
AFE0064 chip is a current integrator which consists of 64-channels. For each channel, 
the analogue differential output which is proportional to the charge accumulated in a 
capacitor during a particular configuration is provided. The chip is set electronically 
through a serial protocol interface on the lowest gain available to span the full scale up to 
9.6 pC, with a resolution of 16 bit and a non-linearity of less than 0.1% [200]. 
The DAQ system uses eight AFE chips to readout all the 512 channels, and the MP512 
signal is synchronized with the Linac pulse. It is read out by four analogue-to-digital 
(ADC) converters. When the beam is on, all acquisitions were synchronised to the Linac 
trigger signal by a field programmable gate array (FPGA). The FPGA DAQ and the Linac 
machine is connected to each other by means of a coaxial cable. The FPGA itself connects 
via a USB 2.0 link to the host computer. The signal from each pixel is acquired in 
synchronisation with each Linac pulse (pulse-by-pulse) or by using an internal trigger at 
a frequency of up to 5 MHz. More details about DAQ system can be found elsewhere 
[201]. 
The CMRP furthermore designed the graphical user software for external beam 
radiotherapy which provides real-time visualisation and flat field correction, however not 
part of this thesis work. While the beam is on, the interface is able to present in both 
instantaneous detector response and integral detector response Figure 3.4 shows the 
software interface for reference and all the commands for the device controller.  
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Figure 3.4: The AFE-MP512 software interface version 1.37. 
 
Due to the different in operational characteristics of photon beam and electron beam 
production, the relevant parameters used in the software interface setting was set as shown 
in Table 3.1. 
 
Table 3.1. Relevant parameters for controlling the AFE-MP512 software interface for 
photon beams and electron beams.  
Parameter Photon Electron 
Range 7 7 
Buffer size (kB) 4096 4096 
Acquisition Length (s) 15 20 
Integration time (µs) 78 20 
Frequency (kHz) 0.36 0.18 
Integration time of offset (µs) 65 65 
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3.4 Ionisation chamber  
 
In the thesis work described here, two types of ion chambers were used including the 
Farmer IC and Markus IC and both are often used as a comparative dosimetry in clinical 
settings. The following details are briefly discussed regarding these two detectors. 
3.4.1 Farmer ionisation chamber 
 
A Farmer chamber (Model 2517A) was used in this thesis for transmission factor (TF) 
measurements. A Farmer ionisation chamber is a thimble-type (or cylindrical) chamber 
which is a fundamental tool for medical dosimetry. The chamber has a cylindrical cavity 
in which an electric field is applied between a conductor coated on the inner surface wall 
and collector electrode that lies along the centre of the cavity. The leakage current from 
the high voltage electrode is prevented by the guard electrode of the thimble chamber. 
The ion-collecting volume is also defined by this guard [202]. Figure 3.5 schematically 
presents the thimble ionisation chamber. The thimble wall is often made of pure graphite 
and the central electrode of pure aluminium with the typical air volume between 0.05-
1.00 cm3. The wall material is designed to be thick enough to establish CPE or TCPE or 
thin enough not to perturb the fluence of charged particles. The wall thickness is about 
0.1 g/cm2. The chamber is at the ground and the guard is kept at the same potential as the 
collector. The chamber radius is typically 2-7 mm and length 4-25 mm [203].   
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Figure 3.5. The schematic representation of thimble ionisation chamber [204] 
 
3.4.2 Markus ionisation chamber 
 
Markus ionisation chamber (Model N23343) was used in this thesis for surface dose 
measurements and percentage depth dose measurements. The Markus is a plane parallel 
ionisation chamber. It has been recommended for the surface dose measurement for 
photon beams and electron beam [173], [205]. This chamber has a flat cavity which can 
minimise in-scattering perturbation effect. The detector consists of a guard ring 
surrounded by the collecting electrode. The purpose of guard ring is to prevent undue 
curvature of the electric field over the collector [173]. An electrode spacing of the detector 
is about 1-2 mm, and the sensitive volume is 0.35 cm3. The collecting surface on an 
insulator is coated with graphite. Figure 3.6 shows a schematic of a parallel plate 
ionisation chamber. 
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Figure 3.6 Schematic drawing of a parallel plate ionisation chamber 
 
Markus ionisation chamber is a good alternative as the extrapolation chambers. However, 
this chamber is known for their over-response due to the secondary electron generated 
from their small guard ring and their internal dimensions [206]. Generally, this effect 
occurs only at build-up region [207].  
All data measured by Markus IC in this thesis is corrected for detector over-response by 
using Velkley correction as modified by Rawlinson [208], [209]. The chamber dimension 
used for correction calculation was obtained from Chen et al. as shown in the equation 
(3.1), (3.2) and (3.3) [210].  
 
𝑃(𝑑, 𝐸) = 𝑃′(𝑑, 𝐸, 𝐺) − 𝜉 (𝑑, 𝐸, 𝐺)                                    (3.1) 
 
𝜉 (𝑑, 𝐸, 𝐺) =  𝜉 (0, 𝐸, 𝐺) 𝑥 𝑒−4.0𝑑/𝑑𝑚𝑎𝑥                                  (3.2) 
 
𝜉 (0, 𝐸, 𝐺) = 𝑐(𝐸) 𝑥 (
𝑠
𝑤
) 𝑥 𝜌0.8                                             (3.3) 
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Where P is the true PDD and P′ is the measured PDD. The ξ is an over response correction 
factor, E is the photon energy, d is the depth in the phantom, 𝜌 is mass density of the 
chamber wall. The s/w is the ratio of electrode separation to the diameter of wall. For 6 
MV and 10 MV photon beam dmax = 1.5 cm and 2.1 cm, respectively. As mentioned in 
Rawlinson study, the c(E) for 6 MV is 27% and for 10 MV is 18.41%. All parameters for 
the original Markus IC is shown in Table 3.2. 
 
Table 3.2. The original Markus Ionisation chamber specification [211]. 
 Wall (w) Collecting electrode Window 
Material Polymethylmethacrylate Graphited PMMA 
Polyethylene 
(CH2) 
Density (g/cm3) 1.189 1.189 0.93 
Diameter (mm) 6 5.3 ˗ 
Separation (mm) ˗ 2 ˗ 
Thickness(mg/cm2) ˗ ˗ 2.5 
 
3.5 Radiochromic Film dosimetry 
 
Gafchromic EBT3 film (ASHLAND, Wayne, NJ) was often used for comparison with 
the dose measured by MP512 such as output factor, wedge beam profile, PDD and IMRT 
plan dose measurement. The characteristic and the usefulness of the EBT3 was briefly 
described in Chapter 2. This section will explain the film workflow that performed in this 
thesis. 
3.5.1 Calibration phase 
 
To characterise the radiation dose sensitivity curve of a batch of EBTS film, dose 
calibration measurements were performed.  
The film sheet was cut into multiple pieces with the size of 3 x 3 cm2. In this thesis, 12 
pieces were used for clinical practice. Each film was Pre-scanned before exposure by a 
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Microtex ScanMaker i800 scanner. In order to warm up the scanner for better film 
analysis consistency, each film was scanned six times, and the last three scan were kept 
for analysis [113]. The film was positioned at the centre of the scanner and was scanned 
in 48-bit RGB colour mode with 70 dpi scanning resolution. All films were placed in the 
same orientation to minimise any uncertainties [113].  
For film dose calibration measurement, the film was positioned at dmax (1.5 cm for 6MV) 
in a solid water phantom and aligned at the beam centre. The full backscatter condition 
was set with 10 cm thick of solid water. A known dose ranging from 0 – 40 Gy was 
delivered to each film.  All calibration setup was repeated for 10 MV photon beams.  
All films were kept for at least 48 hrs for full development at the unexposed UV area to 
avoid any possible darkening of the film [212]. The post-scanning were perform to 
produce the image with the similar scanner setting as the pre-scan. 
To obtain a calibration data from the scanned images, a set of multiple dose optical 
densities (OD) was investigated by two software tools including; the Image J version 
1.48v (National Institute of Health) and MATLAB (The Math Works Inc., Natick, MA). 
The scanned image consists of 3 components; red, green and blue channels, only the red 
channel is used for the dose conversion. Find the average intensity of the interested area 
(at the centre of the film each film) and convert the intensity to the optical density (OD) 
by equation (3.4) [109]. 
 
𝑂𝐷 = log (
𝐼0
𝐼
)                                                            (3.4) 
 
Where I is the intensity (post-scanning value), and I0 is background intensity (pre-
scanning value)  
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Then plot the OD vs the known dose to generate the calibration curve [113], [213]. Devic 
et al. and Battum et al. recommended to fit a non-linear calibration curve with a second 
or higher order polynomial to generate the calibration equation[214], [215]. Figure 3.7 
shows the example of the calibration curve used in this thesis. 
 
 
Figure 3.7. The calibration curve for 6MV photon beam 
 
3.5.2 Measurement phase 
 
Similar to calibration phase, film sheets were cut into the desired size for clinical 
measurement. For instance; the film was cut into a size of 7 x 7 cm2 for output factor 
measurement and 10 x 10 cm2 for IMRT plan delivery. Pre-scanning was performed to 
obtain a background intensity.  
A blank EBT film was then irradiated to the radiation field of interest. A waiting time is 
similar to the calibration phase, and then post-scan the film. The images were converted 
into the dose distribution by converting OD value into the dose using the calibration 
y = 1256.5x2 + 908.98x - 4.1222
-100
0
100
200
300
400
500
600
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4
D
o
se
 (
cG
y
)
OD
Chapter 3: Methodology 
 
45 
equation. The average uncertainty calculated across all measurements by film dosimetry 
in this thesis is approximately 1.98%. 
 
3.6 MOSkin dosimetry 
 
MOSkin was often used as a comparison dosimeter in the part of surface dose 
measurement. The MOSkin is a Metal-Oxide-semiconductor Field Effect Transistor 
(MOSFET) designed and built at CMRP.  
It was designed using a p-MOSFET sensor with a thick gate oxide and sealed within a 
Kapton pigtail strip using drop-in technology [216]. A film layer protects the detector 
from any moist and dust and build layer up providing a water equivalent depth of 0.07mm 
[216]. More advantages of MOSkin are its small physical size and provide real-time 
reading [217]. Figure 3.8 shows a MOSkin dosimetry system and its schematic.  
The characteristic of MOSkin has been previously reported. It showed excellent 
reproducibility and linearly for dose range of 50 cGy to 300 cGy. MOSkin presented 
stability response to various factors such as SSDs, field sizes, surface, radiation incident 
angles, and wedges [216]. It is found to be suitable for in vivo skin dosimetry in 
radiotherapy [217]–[219].  
Similar to MOSFET principle, the difference between two threshold voltage values, ∆Vth, 
was calculated to find the measured absolute dose using the following equation (3.5). The 
calibration factor was initially measured for 10 x 10 cm2 field at a depth of dmax. The time 
gap between two signals was set at 30 seconds [220]. 
 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑐𝐺𝑦) =  
∆𝑉𝑡ℎ (𝑚𝑉)
𝐶𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 (𝑚𝑉/𝑐𝐺𝑦)
                  (3.5) 
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(a) 
 
 
(b) 
Figure 3.8. (a) A MOSkin dosimeter system and (b) MOSkin schematic. 
 
 
 
 
  
 
 
 
 
CHAPTER 4  
OPTIMIZATING THE UPSTREAM AIR GAP 
OF THE MAGIC PLATE 512 WHEN 
OPERATING IN DOSE MODE 
 
This chapter evaluates the impact of an air gap on the MP512 response when operating 
in dose mode for both photon beams and electron beams, i.e. output factor, PDD and 
beam profiles. 
 
4.1 Introduction  
 
Two-Dimensional (2D) silicon diode arrays implemented in radiation therapy quality 
assurance (QA) applications have a lot of advantages such as real time operation, the 
small size of the sensitive volume of a single diode and a large dynamic range. However, 
currently most diode arrays have a detector pitch that is not suitable for routine use in 
small treatment field applications [59], [122], [221], [222]. 
The CMRP introduced a monolithic high spatial resolution silicon detector called Magic 
Plate (MP512). A silicon monolithic detector, the MP512 has a high spatial resolution, 
yet a large, overall size and requires packaging that is associated with non-water 
equivalent materials and air gaps that can affect small field dosimetry measurements.  
The air gap has a significant impact on small field dosimetry since a loss in charge particle 
equilibrium can occur depending on the size of the low density cavity [223], [224].  
Several studies have shown that the reduction in dose is affected by increasing the air gap 
size. 
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Charles et al [225] reported the effect of very small air gaps, less than 1 mm, on small 
field dosimetry used for stereotactic treatments. They simulated by Monte Carlo, the 
response of an optically stimulated luminescent dosimeter (OSLD) in a 6 mm x 6 mm       
6 MV photon field. A dose reduction of about 5% for an air gap of 0.5mm upstream of 
OSLD relative to the simulation with no air gap was observed. A 0.2 mm air gap caused 
a dose reduction of more than 2%. The authors also noted that the thin air gap can cause 
a significant reduction in the measured dose.  
In addition, the air gap can be useful for correcting the response of non-water equivalent 
detectors in small field dosimetry [226].  Charles et al [226] demonstrated that silicon 
diode overresponse relative to water in small fields can be neutralised by a small upstream 
air gap which depends on the diode design and its packaging. That approach led to the 
“air diode” concept for stereotactic dosimetry [227].  
In this chapter, the effect of the upstream air gap on the response of MP512 is 
investigated. The air gap size that changes the response of the MP512 to water in small 
field dose measurements was optimized for both photon beams and electron beams. The 
parameters tested were: 
(a) Output factor (OF) 
(b) Percentage Depth Dose (PDD) 
(c) Wedge beam profile  
The responses of all tests above with different sized air gaps upstream of the MP512 
detector was measured in comparison with EBT3 film, the MOSkin, and an Ionisation 
Chamber (IC).  
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4.2 Materials and Methods 
4.2.1 PMMA slabs for MP512 cover 
 
The MP512 detector was placed between two polymethyl methacrylate (PMMA) slabs. 
The purpose of the PMMA envelope is to protect the detector from mechanical damage 
and to shield the sensor from ambient light [199]. Figure 4.1 shows the MP512 enveloped 
with the PMMA slabs and an example of the PMMA slabs with an aperture at the centre 
area.  This aperture created an air gap between the detector itself and the PMMA slab as 
presented in the schematic diagram shown in Figure 4.2.  
 
 
(a) 
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(b) 
Figure 4.1. a) The MP512 enveloped with the PMMA slabs b) the PMMA slabs with 
different air gap size 
 
 
Figure 4.2. The simplified schematic of the MP512 packaging 
 
By altering the size of this air gap it is possible to affect dosimetric measurements in 
different radiation fields. To investigate the best air gap size for the MP512 detector, the 
air gap thickness between the PMMA slab and the PCB used in this study was adjusted 
between 0.5 mm, 1.0 mm, 1.2 mm, 2.0 mm and 2.6 mm from the PCB surface. Taking 
into account the thickness of the silicon substrate is 0.45 mm, the actual air gap size above 
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the MP512 for the studies described here are therefore 0.05 mm, 0.55 mm, 0.75 mm, 1.85 
mm and 2.15 mm.  
4.2.2 MP512 equalisation  
 
Before performing and dosimetric measurements, equalization of the detector is required 
because the MP512 consists of 512 silicon pixels and each pixel is connected to an 
individual readout input of the multichannel electronics. Based on this information, the 
radiation response is going to be related to the sensitivity of each individual pixel, the 
gain of its corresponding preamplifier channel, etc. Thus, it is possible to generate a flat 
field correction protocol to allow for the small variations of the overall detector system 
response on a pixel by pixel basis.  
This equalization process adjusts the detector values and the detector configuration to 
generate a flat response output from the detector assuming a uniform beam is incident on 
the detector. Figure 4.3 shows the schematic of the equalisation setup. 
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Figure 4.3. The schematic of the equalisation setup 
 
The MP512 was placed at a depth of 10 cm in the solid water phantom with 10 cm back 
scattering. 200 MUs were delivered to a 20 x 20 cm2 field size at SSD of 100 cm. The flat 
field correction can be calculated following equation (4.1), (4.2) and (4.3) [228], [229]. 
The response of the MP512, vector Xi, for all pixels is considered the same. The average 
response from all channels was calculated (X). The equalization factor vector, Fi, was 
then  
 
𝐹𝑖 =
𝑋𝑖
(𝑋)
                                                             (4.1) 
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And the equalised detector response for each pixel, Xeq-i, was then 
 
 
𝑋𝑒𝑞−𝑖 =
𝑋𝑖
𝐹𝑖
                                                        (4.2) 
The detector uniformity can be calculated by the equation (4.3) where Xcen is the vector 
at a central pixel which is located at row 11, column 12.  
 
𝑋% =  
𝑋𝑒𝑞−𝑖−𝑋𝑐𝑒𝑛
𝑋𝑐𝑒𝑛
                                                  (4.3) 
 
The variation in the response of all 512 detectors relative to the average response can then 
be calculated before and after flat field correction for any beam energy desired. 
 
4.2.3 Output Factor measurement  
 
The output factor (OF) presents the dose rate and the amount of radiation exposure 
produced by a treatment machine. It can be defined as the ratio of the dose per monitor 
unit (MU) for a given field size to the reference field size [230]. The reference field size 
in this study is 10x10 cm2 at the source to surface distance (SSD) of 90 cm [13]. Figure 
4.4 shows the MP512 output factor measurement setup. 
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Figure 4.4. The output factor measurement setup of Magic Plate 512 with various 
detector air gaps. 
 
The MP512 was placed on solid water phantom at the depth of 10 cm with an additional 
10 cm of solid water to act as back scatter and was aligned at the centre of the beam. The 
OF was measured for square fields ranging from 0.5 x 0.5 cm2 to 10 x 10 cm2 and was 
deduced based on the response of the central pixel which is located at row 11 and column 
12. The measurements were performed in 6 and 10 MV photon beams with a 600 MU/min 
dose rate. 100 MU was delivered with open field MLCs. The size of the air gap above 
MP512 detector was set at 0.5, 1.0, 1.2, 2.0 and 2.6 mm. The measurements were taken 
three times at least and directly compared with EBT3 films and MOSkin response under 
the same conditions.  
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4.2.4 Percentage Depth Dose (PDD) for 6 MV and 10 MV photon beam 
 
The PDD profiles were acquired using different air gap sizes upstream of MP512 detector. 
The air gaps used for the 6 MV photon beam was 0.5 mm and 2.6 mm, and for the 10 MV 
photon beam they were 1.2 mm and 2.6 mm. The MP512 was placed perpendicular to the 
direction to the central axis (CAX) of the beam at an SSD of 100 cm for field size of 2 x 
2 cm2, 5 x 5cm2 and 10 x 10cm2. The PDDs were obtained by scanning the MP512 from 
a depth of 0.5 cm to 10 cm. The PDDs were normalized to the MP response at the depth 
of dmax for all photon energies investigated. The dmax for 6 MV and 10 MV photon beam 
is 1.5 cm and 2.1 cm, respectively. For all irradiation geometries, 100 MU was delivered 
with a 600MU/min dose rate. The PDD measured by the MP512 with different air gaps 
were directly compared with the PDD response measured by an original Markus IC 
(PTW, Freiburg, Germany, model: N23343) for field sizes of 10 x 10 cm2 and 5 x 5 cm2. 
For the small field size of 2 x 2 cm2 the results were compared to the EBT3 films to gain 
an understanding of the impact of any volume averaging effects as well as any beam 
perturbation effects from the window thickness of the ionisation chamber [231].  
 
4.2.5 Wedge beam profile measurements for 6 MV photon beam 
 
Wedge beam profile measurements were done using a 5 x 5 cm2 radiation field size which 
was the smallest field the Linac can generate for enhanced dynamic wedge (EDW) field. 
The EDW profiles were produced by varying the jaw position and/or the output rate 
during the treatment dose delivery. The EDW of 15°, 45° and 60° were used for this study 
and generated by Varian Linac (model 2100IX).  The MP512 was placed at a depth of 10 
cm in solid water phantom and aligned on the central axis of the beam. A 100 MU was 
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delivered at 100 cm SSD for each wedge angle for a 6 MV photon beam. The air gap sizes 
of 0.5 mm and 2.6 mm were used as part of this particular study.  
To convert the MP512 response to dose (Gy) the MP512 responses were multiplied by 
the calibration factor (CF). To obtain the CF, the MP512 was placed at a depth of Dmax, 
the dose-maximum depth, and exposed to a 10x10 cm2 field size at the 100 cm SSD. The 
calibration factor can be calculated using equation (4.4) below where “MU” is the known 
MU delivered to the MP512 and “MP” is the average response of the central pixel of the 
MP512. 
 
𝐶𝐹 =
𝑀𝑈
𝑀𝑃
                                                            (4.4) 
 
The dose measured by the MP512 was directly compared with the independently 
calibrated EBT3 film response measurements made under the same conditions 
 
4.2.6 Percentage Depth Dose for electron beams 
 
The PDD measurements in electron beam fields were performed in the same solid water 
phantom. The SSD was set to 100 cm. A 10 x 10 cm2 applicator and a standard cerrobend 
cutout of 10 x 10 cm2 were used to define the electron field dimensions. The MP512 was 
placed in the solid water phantom and aligned at the centre of the beam. The 
measurements were performed at a depth of 0.5 cm to 10 cm in a solid water phantom. 
The results were investigated for 6 MeV, 12 MeV and 20 MeV electron beams with air 
gap sizes of 0.5 mm and 2.6 mm. All measurements were performed at least three times. 
The results were compared with the PDD measured by Markus IC.  
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4.2.6.1 Use of plastic phantom for depth dose measurement 
correction 
 
The IAEA has recommended that to measure a central-axis depth dose for electron beam 
in a plastic phantom, the dosimeter reading at each depth must be scaled because for the 
electron beam, the water-to-air stopping power ratio, Sw,air, changes rapidly with depth 
[232]. In this part of the study, the electron beam depth dose measured by an ion chamber 
was followed using the code of practice for radiotherapy dosimetry, TRS-398 [75].  
In this study, the solid water phantom; RMI-457 was used for the measurements. The 
equivalent depth in water, Zw, can be calculated by equation (4.5) below. 
 
𝑍𝑊 =
𝑍𝑃𝑙
𝐶𝑃𝑙
                                                       (4.5) 
 
Where Zpl is the depth in the solid water phantom (cm) multiplied by Ppl.  
 
Ppl is the density of the plastic, Ppl for the solid water (RMI-457) is 1.030 gcm
-3. Cpl is the 
depth scaling factor, Cpl for the solid water (RMI-457), which is 0.949 gcm
-3. 
 
The reading from the Markus IC was multiplied by the fluence-scaling factor, hpl, for 
certain plastics to find the equivalent reading at Zref in water (MQ) as presented in equation 
(4.6).  
 
𝑀𝑄 = 𝑀𝑄,𝑝𝑙ℎ𝑝𝑙                                                   (4.6) 
 
Where MQ, pl is the IC reading at the scaling depth in water (Zw), and the hpl is the fluence 
scaling factor. The fluence scaling of the solid water (RMI-457) is 1.008. 
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All IC current, MQ, was then multiplied by the appropriate stopping-power-ratio, Sw,air, at 
each depth. Table 4.1 summarizes the stopping-power-ratio as a function of beam quality 
R50 (g cm
-2) and relative depth Z/R50 in water of each depth use for electron beam PDD 
measurement is this study [75].   
 
Table 4.1. The water-to-air to stopping-power-ratio for 6 MeV, 12 MeV and 20 MeV as 
a function of beam quality R50 and relative depth Z/R50. 
6 MeV 12 MeV 20 MeV 
Depth (cm) Sw, air Depth (cm) Sw, air Depth (cm) Sw, air 
0.50 1.0500 0.50 1.0000 0.50 0.97 
0.70 1.0600 1.00 1.0100 1.00 0.98 
1.00 1.0700 2.00 1.0400 2.00 0.99 
1.20 1.0800 2.50 1.0500 2.60 1.00 
1.30 1.0800 2.90 1.0600 4.00 1.02 
1.50 1.0900 3.90 1.0900 6.00 1.06 
2.00 1.1100 4.50 1.1100 6.10 1.06 
2.30 1.1300 5.00 1.1200 7.00 1.08 
2.50 1.1400 5.50 1.1400 7.50 1.09 
3.00 1.1700 6.50 1.1700 9.00 1.13 
3.50 1.1800 10.00 1.3180 10.00 1.16 
5.00 1.2700 ˗ ˗ ˗ ˗ 
*R50 = R50 in water x Cpl 
**R50 of 6 MeV, 12 MeV and 20 MeV = 2.18 gcm-2, 4.65 gcm
-2 and 7.97 gcm-2  
 
4.3 Results and discussion 
4.3.1 Output factor for 6 MV and 10 MV photon beam 
 
The average of the four central pixels of the MP512 was evaluated for the OF 
measurements. The MP512 uncertainty was found to be 0.2% (1 s.d.) for all 
measurements.  Figure 4.5 and Figure 4.6 show the OF measured by the MP512 at a depth 
of 10 cm in solid water phantom for different air gaps above detector compared to the 
EBT3 film and MOSkin (with no air gap above them). The response is normalized to the 
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response measured in a 10 x 10 cm2 field size, for 6 MV and 10 MV, respectively. Figure 
4.5 illustrates that at small field sizes the OF measured with the MP512 reduces with 
increasing detector air gap. A significant effect of the air gap size has been observed for 
a 0.5 and 1 cm2 field size. The air gap has negligible effect for field sizes larger than 4 x 
4 cm2 for the air gap of 0.5 mm, 1 mm and 1.2 mm above the detector. the MP512 with 
the air gap of 0.5 mm shows good agreement to the output factors measured with the 
EBT3 film and MOSkin within ±2% (1 standard deviation) for very small field sizes up 
to 3cm2 and not more than 3 % for 3-5 cm2 and no difference with field size increasing 
(zero for 10x10 cm2 ). 
As expected, for small radiation fields of 0.5 x 0.5 cm2 and 1 x 1 cm2 the output factor 
reduces with the air gap increasing for the 10 MV photon beam as presented in Figure 
4.6. The MP512 response with air gap size of 1.2 mm best matched the output factors 
measured with the EBT3 and MOSkin within ±2% for field sizes smaller than 4x4 cm2 (1 
standard deviation) for 10 MV photon beam fields.  
 
With increasing of radiation field size, the effect of an electronic disequilibrium produced 
by air gap is diminishing. It is explained by the fact that laterally scattered radiation 
dominate response of the MP512 in comparison with lack of secondary electrons 
generated in an air gap.  It is confirmed by experimental results. At field size of 0.5 x 0.5 
cm2 and 1 x 1 cm2, the percentage different between MP512 and EBT was more than 12% 
when the air gap size increased from 0.5mm to 2.6 mm. Similar behavior was observed 
when compared with the MOSkin detector. While at field sizes 4x4 cm2 the output factor 
measured with MP512 difference of the output factors measured by ETB3 and MOSkin 
is about only 5-7% when the air gap size increased from 0.5 mm to 2.6 mm and is not 
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changing at all for 10x10 cm2 filed size. Based on these studies the optimal air gap was 
selected to match OF measured with MP512 to the film.   
 
 
 
(a) 
 
 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
0.0 2.0 4.0 6.0 8.0 10.0 12.0
O
u
tp
u
t 
F
ac
to
r
Field Size (cm2)
MP512
EBT3
Moskin
0.00
1.00
2.00
3.00
4.00
5.00
0.0 2.0 4.0 6.0 8.0 10.0 12.0%
 D
if
fe
rr
en
ce
Field Size (cm2)
MP512 VS EBT3
MP512 VS Moskin
Chapter 4: Optimization of the air gap upstream the MP512 when operate in dose mode 
 
61 
 
 
(b) 
 
 
 
(c) 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
0.0 2.0 4.0 6.0 8.0 10.0 12.0
O
u
tp
u
t 
F
ac
to
r
Field Size (cm2)
MP512
EBT3
Moskin
0.00
1.00
2.00
3.00
4.00
5.00
0.0 2.0 4.0 6.0 8.0 10.0 12.0%
 D
if
fe
re
n
ce
Field Size (cm2)
MP512 VS EBT3
MP512 VS Moskin
0.00
0.20
0.40
0.60
0.80
1.00
1.20
0.0 2.0 4.0 6.0 8.0 10.0 12.0
O
u
tp
u
t 
F
ac
to
r
Field Size (cm2)
MP512
EBT3
Moskin
0.00
4.00
8.00
12.00
16.00
0.0 2.0 4.0 6.0 8.0 10.0 12.0
%
 D
if
fe
re
n
ce
Field Size (cm2)
MP512-EBT3
MP512-Moskin
Chapter 4: Optimization of the air gap upstream the MP512 when operate in dose mode 
 
62 
 
 
(d) 
 
 
 
(e) 
Figure 4.5. Field size response of the MP512, EBT3 film and MOSkin for a 6 MV 
photon beam, normalized to the response measured in a 10 x 10 cm2 field size at a depth 
10 cm in a solid water phantom for different air gaps of (a) 0.5 mm, (b) 1.0 mm, (c) 1.2 
mm, (d) 2.0 mm and (e) 2.6 mm 
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(d) 
 
Figure 4.6. Field size response of the MP512, EBT3 film and MOSkin for a 10 MV 
photon beam normalized to the response at 10 x 10 cm2 field size at a 10 cm depth in a 
solid water phantom and air gap of (a) 0.5 mm, (b) 1.0 mm, (c) 1.2 mm, (d) 2.0 mm and 
(e) 2.6 mm. 
 
4.3.2 Percentage Depth Dose (PDD) for 6 MV and 10 MV photon beams 
 
Figure 4.7 and Figure 4.8 present the PDD measured with the MP512 in a solid water 
phantom for 0.5 mm and 2.6 mm air gap upstream of the detector for different field sizes 
in comparison with a Markus IC for 6 MV and 10 MV photon beams, respectively. All 
reading from the Markus IC has been corrected for over-response by using the corrected 
factor is given by Chen et al [210]. Similar results were observed for the photon beam 
PDD measurements. As the size of the air gap above the detector increased, the PDD 
demonstrated a detectable decrease field size of 5 x 5 cm2 and 10 x 10 cm2.The PDD for 
2 x 2 cm2 field was within ±3% (1 SD) of the EBT3 for both photon energies. For field 
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size 5x5 cm2 and 10x10 cm2, the PDD measured with the MP512 is within ±1.6% (1 SD) 
and ±1.5% (1 SD) of that measured using a Markus ionisation chamber for 6 and 10 MV 
fields respectively. 
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(b) 
 
 
 
( c) 
 
Figure 4.7. PDD measured with 0.5 mm and 2.6 mm air gap above the MP512 of 6 MV 
photons in comparison with an ionisation chamber and EBT3 film for field sizes of (a) 
10x10 cm2, (b) 5x5 cm2 and (c) 2x2 cm2. 
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(c) 
 
Figure 4.8. PDD measured with 1.2 mm and 2.6 mm air gap above the MP512 of 10 
MV photons in comparison with an ionisation chamber and EBT3 film for field sizes of 
(a) 10x10 cm2, (b) 5x5 cm2 and (c) 2x2 cm2. 
 
4.3.3 Wedge beam profile for photon beams 
 
Figure 4.9 shows the beam profile measured in the wedge direction at a depth of 10 cm 
for the MP512 with a 0.5 mm and 2.6 mm air gap above the detector in comparison with 
EBT3 film.  The EDW dose profile matches well with the EBT3 for the air gap of 0.5 
mm, within ±1% (1 SD), except at the toe and heel region where the difference was within 
±3% (1 SD) for all wedge angles. The difference increases with an increase in the air gap 
size. For the 2.6 mm air gap, the difference on the heel side was observed to be about 
±10% (1 SD). The Wedge profiles show that if only the flattened area of the field is 
considered, the maximum difference between profile and the EBT3 film is within ±1% 
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for small air gap size 0.5mm for all wedges angles. There is a significant difference in the 
shape of the wedge profile when a 2.6 mm air gap size is used. 
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(b) 
 
 
(c) 
 
Figure 4.9. Wedge beam profiles measured with the MP512 with different air gaps in 
comparison with those measured using EBT3 film at a depth of 10 cm for 6 MV photon 
beam with a field size of 5x5 cm2 (a) 15° Wedges, (b) 45° Wedges and (c) 60° Wedges. 
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4.3.4 Percentage depth dose for electron beams 
 
The PDD measured by the MP512 in electron beams demonstrated no significant effect 
with increasing air gap above the MP512 for all energies. The correction for use of the 
plastic phantom for electron depth dose distributions follows the TRS398 instruction [75].  
The results for both 0.5 mm and 2.6 mm air gap are within ±3% (1 SD) of similar 
measurements made using the Markus IC and are shown in Figure 4.10. 
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(b ) 
 
 
(c) 
 
Figure 4.10. PDD measured with MP512 and 0.5 mm and 2.6 mm air gap upstream of 
the detector on electron beams for a field size 10 x 10 cm2 in comparison with a Markus 
ionisation chamber in a solid water phantom for electron beam energies of (a) 6 MeV, 
(b) 12 MeV and (c) 20 MeV. 
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4.4 Conclusion  
 
The MP512 response with different air gaps upstream of the detector in a solid water 
phantom have been investigated in both photon and electron fields. The results obtained 
in this study show that the air gaps cause a measurable dose reduction for small radiation 
field sizes due to the loss in electron equilibrium. Based on these findings, we have tried 
to optimize the air gap size for a monolithic diode array detector, MP512 for both photon 
and electron fields. The studies confirmed that the MP512 monolithic diode array is 
suitable for QA of small fields in a phantom. The small air gap of 0.5 mm and 1.2 mm is 
the best air gap for small field dosimetry in 6 MV and 10 MV photon beams, respectively. 
However, the effect of air gap on electron beams is not significant due to electronic 
equilibrium conditions being fully established and maintained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
CHAPTER 5  
DOSIMETRIC IMPACT OF MAGIC 
PLATE512 OPERATING IN TRANSMISSION 
MODE ON CLINICAL PHOTON BEAMS 
 
This chapter describes, from a dosimetry perspective, the impact of the monolithic silicon 
detector, MP512 when operating in transmission mode, so named MP512 T.  In particular 
I studied the effect of the MP512T on the surface dose as a function of different field sizes 
and the specific MP512T detector mounting position between the solid water phantom 
and the Linac head. As part of my work the unique transmission factor for the MP512T 
and the PCB were evaluated.   
 
5.1 Introduction 
 
The Magic Plate 512 has been previously reported in dose mode measurements for 
SRS/SBRT verification [168]. Further investigation, including the effect of the air gap 
size above the detector, has been discussed in the previous chapter of this thesis. The 
MP512 with the difference in the detector packaging called MP512T (described in 
Chapter 3) has been designed to be used as a transmission detector for real time dose 
reconstruction measurements.  
Any radiation beam perturbation, in particular any surface dose increase, is of significant 
interest due to its impact on clinical outcomes associated with transmission type detectors 
[156], [162], [164], [233]. As a transmission-type detector, a detailed study for the 
MP512T is therefore required to assess its future clinical suitability. 
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The MP512T, in contrast to the previously characterized transmission magic plate 
detector called MP121 [234] is essentially different in design and has a much improved 
spatial resolution. The details of the MP121 were described in Chapter 2. The MP512T 
is a monolithic silicon detector that can lead to different perturbation of the skin dose in 
megavoltage photon fields. Additionally, the MP121 was characterized only when the 
detector was attached to the Linac head. Unlike the MP121, the MP512T system is 
designed to be placed at various distances between the Linac head and the solid water 
phantom surface. Therefore, it is important to investigate, understand and quantify any 
effect on the skin dose of the different MP512T detector operating positions. 
This chapter will investigate the Magic Plate 512T when operating in transmission mode, 
on beam perturbation, in particular on the surface dose and beam transmission with 
different field sizes and positions between the solid water phantom and Linac head.   
 
 
5.2 Materials and Methods 
 
5.2.1 A concept of transmission movable high resolution 
 
Figure 5.1. The concept of using a transmission monolithic silicon detector providing a 
flexible resolution by using a variable detector to surface distance, Dsd, by moving the 
detector between the Linac head and the patient. Figure 5.1 shows a concept of the 
transmission monolithic silicon detector providing flexible spatial resolution by changing 
detector distances from the solid water phantom (Dsd). Moving the detector along the 
beam axis between the patient surface and the Linac  
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head enables the effective spatial resolution of the detector monitoring the radiation field 
to change due to the beam divergence. As the tumour size decreases, moving the detector  
close to the patient provides a higher effective spatial resolution while allowing the 
monitoring of the entire treatment field. 
 
 
 
Figure 5.1. The concept of using a transmission monolithic silicon detector providing a 
flexible resolution by using a variable detector to surface distance, Dsd, by moving the 
detector between the Linac head and the patient. 
 
The proposed movable transmission, high effective spatial resolution silicon monolithic 
detector has another advantage in comparison with the currently used transmission  
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detectors mounted on the Linac head. By moving the detector below the Linac head, the 
contribution of electrons scattered from the head of the Linac on the response of the 
detector is minimized, and the detector response is mostly driven by the photon energy 
fluence, which should simplify the 3D dose reconstruction algorithm.  
 
 
5.2.2 A movable stand detector holder 
 
The MP512T detector was mounted on a movable stand in order for the detector to be 
positioned between the Linac head and the solid water phantom at any distance from the 
phantom surface. The movable stand is made from a PMMA plastic. The holder arms are 
40 cm in length and can be adjusted to fit the detector assembly up to a width of 45 cm. 
The holder has the capability of moving in the vertical direction. When placing MP512T 
on the movable stand holder, only the detector itself was irradiated. Figure 5.2 shows the 
movable stand and its geometry.  
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Figure 5.2. The movable stand and its geometry 
 
5.2.3 The influence of MP512T on the surface dose 
 
To obtain the surface dose, a Markus ionisation chamber (PTW, Freiburg, Freiburg, 
Germany, model N23343) was positioned at the surface of the solid water phantom at 
central axis (CAX) corresponding to the isocentre, with 100 cm SSD. The back scattering 
solid water phantom was 10 cm thick. The IC was read out by PTW UNIDOS model 
T10002-20713 electrometer. All readings from the Markus IC have been corrected for 
over response by using the corrected factor given by Chen et al. [210] described in 
Chapter 3.  
The perturbation of the surface dose was reported as a percentage difference of the surface 
dose measured with MP512T in a beam to open field. Both MP512T and the Markus IC 
were aligned at the centre of the beam. All measurements were performed using a 6 MV 
photon beams from a Varian linear accelerator (Model 21XI). For each measurement, a  
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200 monitor unit (MU) was delivered. The MP512T distance from the solid water 
phantom surface was varied from 0.3 cm to 24 cm. The measurements were carried out 
for irradiation field sizes (IFS) of 5 x 5 cm2, 8 x 8 cm2 and 10 x 10 cm2 with the MLC 
matched with the Linac jaws. The measurement setup is shown in Figure 5.3. 
 
 
(a) 
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(b) 
Figure 5.3. The measurement setup (a) with and (b) without MP512T in a beam. 
 
 
The radiation field size is defined at the SSD of 100 cm. Thus, the effective irradiation 
field size at MP512T position depends on the distance away from the solid water phantom 
and ranges about from 3 x 3 cm2 to 7 x 7 cm2 at the Linac head placement.  
Table 5.1 presents the actual field size on MP512T detector at various distances from the 
solid water phantom surface.  
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Table 5.1. The field size of the MP512T detector at various distances from the solid water 
phantom surface.  
 
Dsd(cm) Field size (cm2) 
0.00 5.00 8.00 10.00 
0.30 4.99 7.98 9.97 
4.50 4.78 7.64 9.55 
9.00 4.55 7.28 9.10 
13.50 4.33 6.92 8.65 
18.00 4.10 6.56 8.20 
20.00 4.00 6.40 8.00 
22.00 3.90 6.24 7.80 
24.00 3.80 6.08 7.60 
 
To examine the reproducibility of the Markus IC the readings were acquired three times 
at least under the same conditions. The detector measurement uncertainty was found to 
be ± 0.2% (1 s.d.).  
 
5.2.4 The influence of the MP512T on the surface dose when placed face up 
and face down 
 
The influence of the MP512T on the surface dose when placed at different Dsd face up 
and face down were evaluated. The set of measurements as section 5.2.3 was repeated. 
Figure 5.4 shows the schematic of the surface dose measurement setup with MP512T in 
a beam (a) face up; (b) face down. For each position and field size, the readings are 
obtained at least three times, and the average was calculated.  
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(a) (b) 
 
Figure 5.4. Schematic of MP512T (a) face up and (b) face down 
 
5.2.5 Effect of Printed Circuit Board on MP512T surface dose measurement 
 
To evaluate the effect of the 0.5 mm thick printed circuit board (PCB) only on the surface 
dose, the PCB without the mounted silicon detector was placed on the movable stand. 
The surface dose measurements were performed using the Markus IC in a solid water 
phantom for open fields and with the PCB in the beam similar to that described in section 
5.2.3.  
 
5.2.6 The transmission factor measurement 
 
The transmission factor (TF) of the MP512T and the PCB were investigated by measuring 
a ratio of the doses at dmax corresponding to the filed 10 cmx10cm, i.e.at depth in a 
phantom 15 mm depth with and without MP512T in a beam for radiation field size 5x5 
cm2, 8x8 cm2 and 10x10 cm2 and SSD of 100 cm for a 6 MV photon beam. The MP512T 
was placed in the beam at different Dsd ranging from 0.3 cm to 24 cm. A Farmer IC 
(Model 2571A) was used for dose measurements. The same set up was repeated at a depth 
of 10 cm and a source axial distance (SAD) of 100 cm for a 6 MV photon beam. 
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5.3 Results 
5.3.1 The influence of MP512T on the surface dose 
 
Figure 5.5 shows the percentage difference of surface dose with and without MP512T in 
the beam path as a function of field size and distance from the solid water phantom 
surface. The percentage difference was calculated follow equation (5.1). 
 
%Diff =  (
with MP512−without MP512
without MP512
) 𝑥100 ……………………… (5.1) 
 
The maximum difference of surface dose was nearly 30% (1 standard deviation), and this 
was found at the distance of 0.3 cm especially in the large 10 x 10 cm2 field. The 
difference in surface dose decreased with increasing distance of MP512T from the solid 
water phantom surface. At Dsd>18 cm the difference was less than 5% (1 standard 
deviation) for all IFSs. At a small field size of 5 x 5 cm2, the percentage difference was 
within ±1 % (1 standard deviation). 
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Figure 5.5. The percentage difference of surface dose with and without MP512T in a 
beam as a function of distance of MP512T from the phantom surface and field size for a 
6 MV photon beam. 
The effect of MP on surface dose increasing is increasing with reducing distance between 
Magic Plate and surface of the phantom. This explain by the fact that  surface dose has 
three  component one is due to electron  contamination originated from scattered electrons 
in a linac head, second is from  electron generated in air between linac head and the 
phantom surface and third  due to electrons scattered from MP. On the other hand MP is 
attenuated and scattered partially electrons originated above MP. Based on obtained 
results attenuation of electrons by MP is not essential and combined effect is increasing 
of the skin dose with reducing Dsd. It is explained by the fact that size of the photon field 
incident on a MP is increasing with Dsd decreasing that is leading to more secondary 
electrons originated from MP scattered to the phantom surface and surface dose 
increasing respectively. This effect is more pronounced with filed size increasing that is  
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reflected in a Fig 5.5.  For Dsd larger than 18 cm the effect of electron scattered from the 
MP is not essential in comparison with other two electron components as a photon filed 
size seeing by MP is small was observed. 
5.3.2 The influence of the MP512T on the surface dose when placed face up 
and face down 
 
Figure 5.6 shows the percentage difference of surface dose when MP512T is placed face-
up and face-down at various distances from the phantom surface and different IFSs. The 
percentage difference was calculated follow equation (5.2). 
 
%Diff = (
𝑀𝑃512 𝑓𝑎𝑐𝑒 𝑑𝑜𝑤𝑛−𝑀𝑃512 𝑓𝑎𝑐𝑒 𝑢𝑝
𝑀𝑃512 𝑓𝑎𝑐𝑒 𝑢𝑝
) 𝑥100 ……………….(5.2) 
 The difference was within 2.5 % (1 standard deviation) for all distances and field sizes. 
 
Figure 5.6. The percentage difference of surface dose when MP512T is face-up and 
face-down in the beam as a function of distance from the phantom surface and field size 
for a 6MV photon beam. 
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Difference in skin dose changing for face down and face up configuration has tendency 
of slight skin dose increasing for face down configuration for smaller fields when more 
electron scattered down from the silicon MP not attenuated by PCB than in case of face 
up configuration. For 10cmx10 cm field size in MP plane is always larger than size of the 
silicon MP for all Dsd and total electron scattering towards the phantom surface do not 
make such difference as scattering from PCB outside from the silicon MP is the same for 
both configurations 
5.3.3 The effect of printed circuit board on the surface dose 
 
Figure 5.7 shows the percentage difference of the surface dose measured with and without 
the PCB in the beam. The percentage difference was calculated follow equation (5.3). 
 
%Diff = (
𝑤𝑖𝑡ℎ 𝑃𝐶𝐵−𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑃𝐶𝐵
𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑃𝐶𝐵
) 𝑥100……  ……………….(5.3) 
 
Similarly, to Figure 5.5, the surface dose difference increased when the PCB was closer 
to the phantom surface. At PCB distances of more than 18 cm, the percentage difference 
is close to zero for all IFSs. At a PCB distance of 0.3 cm, the surface dose increased by 
about 15% (1 standard deviation) for all IFSs. 
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Figure 5.7. The percentage difference of the surface dose with and without the PCB in a 
beam as a function of distance of the MP512T from the phantom surface and for various 
field sizes in a 6 MV photon beam. 
The effect of PCB only of surface dose increasing with Dds decreasing for all field sizes 
is explained as in 5.3.1 
5.3.4 The transmission factor measurement 
 
At the 6 MV dmax depth, the relative dose difference increases slightly with decreasing of 
the distance (from 18 cm to 0.3 cm) between the phantom surface and the MP512T (or 
blank PCB). The TF was calculated follow equation 5.4. 
 
TF = (
𝑤𝑖𝑡ℎ 𝑀𝑃512
𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑀𝑃512
)………………………………..(5.4) 
 
For Dsd <18cm the TF changes by 1.5-2.0 % (1 standard deviation) and 0.5% (1 standard 
deviation) for MP512T and PCB respectively for all IFSs and all distances above 18 cm  
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is close to 1. These results are presented in  
Table 5.2. Similar behaviour of the transmission factor is observed at a depth of 10 cm as 
shown in  
 
Table 5.3. 
 
Table 5.2. Measured TF at dmax for 6 MV photon beam, SSD =100 cm. The TF is 
presented separately for various distances and IFSs for MP512T and the PCB 
Dsd (cm) 
MP512T  PCB 
5x5 cm2 8x8 cm2 10x10 cm2  5x5 cm
2 8x8 cm2 10x10 cm2 
0.30 1.0130 1.0151 1.0198  1.0055 1.0058 1.0067 
4.50 1.0120 1.0141 1.0186  1.0051 1.0054 1.0062 
9.00 1.0096 1.0104 1.0133  1.0032 1.0038 1.0046 
13.50 1.0040 1.0047 1.0069  1.0018 1.0026 1.0029 
18.00 0.9985 0.9993 0.9996  0.9980 0.9982 0.9989 
20.00 0.9981 0.9990 0.9988  0.9978 0.9982 0.9990 
22.00 0.9975 0.9977 0.9991  0.9980 0.9980 0.9980 
24.00 0.9971 0.9980 0.9985  0.9976 0.9975 0.9973 
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Table 5.3 Measured TF at a depth of 10 cm for 6 MV photon beam, SAD =100 cm. The 
TF is presented separately for various distances and IFSs for MP512 and the PCB 
Dsd (cm) 
MP512T  PCB 
5x5 cm2 8x8 cm2 10x10 cm2  5x5 cm
2 8x8 cm2 10x10 cm2 
0.30 1.0190 1.0200 1.0220  1.0122 1.0129 1.0137 
4.50 1.0182 1.0190 1.0216  1.0120 1.0124 1.0131 
9.00 1.0132 1.0147 1.0159  1.0085 1.0099 1.0105 
13.50 1.0069 1.0076 1.0092  1.0059 1.0063 1.0062 
18.00 1.0022 1.0032 1.0037  1.0018 1.0024 1.0030 
20.00 1.0020 1.0022 1.0020  1.0012 1.0019 1.0020 
22.00 1.0010 1.0012 1.0015  0.9991 0.9993 0.9994 
24.00 0.9993 0.9997 1.0011  0.9991 0.9989 0.9992 
 
 
5.4 Discussion 
 
Quality Assurance (QA) in advanced treatment radiotherapy techniques such as SRS and 
SBRT is complicated due to the small field delivery using IMRT or VMAT for SBRT 
and high definition of the MLCs and small cones for SRS. Thus, the treatment verification 
requires high spatial resolution QA tools, which accurately provide the relevant dose 
information in real-time during the treatment delivery for each gantry angle. Thus, a new 
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QA device, the monolithic silicon pixelated detectors MP512T was introduced. The 
MP512T provides a variable, yet high, effective spatial resolution due to its ability to be  
 
 
placed at different positions in the beam between the Linac head and the patient. In this 
way, the beam projection at any depth is within the area of silicon detector or PCB and  
avoids the effect of attenuation by a PMMA frame (Figure 5.1). These detectors allow 
one to obtain a variable effective spatial resolution from 2 mm to 4 mm depending on the 
position of the detector on the beam axis relative to the Linac head. Another advantage 
of this approach is the reduction of the contribution of scattered electrons from the Linac 
head to the response of the transmission detectors. The thin silicon substrate 0.45 mm and 
0.5 mm PCB is a prerequisite to minimize any beam perturbation.  
It was demonstrated that the MP512T and the PCB alone increases the surface dose due 
to Compton electrons originating from the silicon and the PCB. The partial contribution 
of the PCB alone led to the rise in the surface dose of about 60% compared to the increase 
in the surface dose from MP512T (Figure 5.5 and Figure 5.7). Taking into account that 
the Compton electrons, in this case, are mostly of a MeV energy range, it suggests that 
an opening or recess in the PCB under the silicon monolithic detector active area is 
recommended to further reduce the skin dose excess by a factor of two for all the IFSs 
considered. We also demonstrated that in the face-up or face-down orientation the 
MP512T makes only a 2% (1 standard deviation) difference in the excess surface dose 
(Error! Reference source not found. 5.6) and will be close to zero if an opening or 
recess is introduced in the PCB substrate. A thin light protective coating should be 
introduced above the silicon detector to avoid stray light influencing the detector 
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response. It can easily be achieved by adding a black filler to the thin layer of resin 
protecting the silicon detector.  
The transmission coefficient of the MP512T measured at dmax 15 mm is close to 1 with a 
deviation of about 1.010-1.020 with decreasing distance between the MP512T and the  
 
 
phantom surface below 18 cm. The effect of the MP on dose modification at depth 15mm 
and 100 mm was less than 1% for Dsd large than 13.5cm that is within dose modification  
tolerance and less than 2.2% for all other Dsd (see Tables 5.2 and 5.3). It is recommended 
for in vivo application not to use Dsd less than 13.5 cm that is safe in terms of avoiding 
collision with the patient body and for in a phantom QA to introduce correction  to 
measured dose in case of measured dose based on transmission MP for Dsd less than 
13.5cm.  Providing an opening in the PCB under the silicon monolithic detector will make 
the transmission coefficient closer to 1 for any placement of the proposed transmission 
detectors between the patient and Linac head. 
 
 
5.6 Conclusions 
 
The MP512T detector used as a transmission detector with a variable spatial resolution 
of up to 1 mm at variable positions between the Linac head has been introduced. The 
MP512T is characterized by its minimal beam perturbation. Spatial resolution in 
dosimetry of the small photon beams can be improved by moving the MP512T along the 
beam axis with the best spatial resolution reported when the detector is closest to the 
surface of the patient. Further reduction of the skin dose excess can be achieved by 
reducing the silicon substrate thickness to 0.3 mm and utilizing a drop-in packaging style 
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for the detector [228] on the PCB with the recess accommodating the monolithicsilicon 
detector.  
The mechanical realization of the proposed transmission detector in a clinical scenario is 
still to be done but will be straight forward and will be realized by a telescopic jig attached 
to the Linac head slot, and wireless reader developed at CMRP similar to other 
transmission [156], [160], [164], [235].  
 
  
 
 
 
CHAPTER 6  
 QA OF AN INTENSITY MODULATED 
RADIOTHERAPY CLINICAL SCENARIO 
USING THE MP512T WITH VARIABLE 
SPATIAL RESOLUTION 
 
This chapter extends the work of the previous chapter. The MP512T placed on the 
movable stand position between the Linac head and the solid water phantom will 
completely use with the data acquisition system. This chapter discusses the correlation of 
transmission mode response (TM) and dose mode response (DM) of the MP512T for dose 
prediction at dmax. 
 
6.1 Introduction 
 
The quality assurance (QA) of SRS and SBRT treatments are complex due to the use of 
small field delivery techniques using IMRT or VMAT for SBRT employing either high 
definition MLCs and/or small cones in the case of SRS, [37], [41], [177], [236], [237]. 
Many devices have been developed for pre-treatment verification such as two-dimensional 
(2D) detector arrays based on ionisation chamber (IC) and semiconductor detectors [59], 
[117], [122], [238]–[240]. 
There is a considerable demand for real-time dose delivery verification. Such QA 
technology enables a real-time detection of major errors in the delivered dose [62]. In 
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particular Electronic Portal Imaging Devices (EPIDs) have been used for real-time 
verification. The method can be used for fixed gantry IMRT treatment, and it is not yet 
available for dynamic arc treatment [153], [154], [241].  
A real-time dose measurement can also be carried out using transmission-type detectors 
where the detector is positioned in the photon beam between the Linear Accelerator 
(Linac) head and the patient. Commercially available transmission-type detectors such as 
the David system (PTW-Freiburg, Germany), Dolphin system (IBA Dosimetry, 
Germany), the Compass system (IBA, Dosimetry), the Delta4 (ScandiDose, Sweden), and 
the integral quality monitoring system (IQM) are based on pixelated ionisation chambers 
and semiconductor diode arrays. The use of these systems result in a change of beam 
characteristics and lead to an increase in the surface dose [156], [157], [160], [162], [164].  
Although, some transmission QA dosimetry devices are available and perform well for 
larger fields, their spatial resolution and resulting perturbation of the radiation field due to 
their design, limits their utilization as a part of a routine clinical practice for small field 
real-time treatment verification.  
The aim of this chapter is to investigate the possible correlation of the MP512T when 
using it in transmission mode (TM) and dose mode (DM) for different Dsd and treatment 
field sizes. The dose at dmax for regular field sizes and intensity modulated treatment fields 
has therefore been calculated using a direct linear correlation found between the MP512 
DM and TM measurements. 
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6.2 Material and methods 
 
6.2.1 Experimental Setup 
  
The MP512T was placed on the movable stand made form a PMMA plastic, as described 
in chapter 5, so the detector can be positioned between the Linac head and the solid water 
phantom at various distances from the phantom surface.  Compared to other transmission 
detectors where the detector is mounted on the Linac head, the use of a movable 
transmission monolithic detector that can be mounted away from the Linac head reduces 
electron scatter, and therefore the photon energy fluence can be measured more accurately.  
The changes in the surface dose observed when placing the MP512T in the air between 
the Linac head and the phantom has been discussed in the previous chapter. The MP512T 
detector produced only minimal perturbations and was fully transparent for 6 MV photon 
beams when placed at a Dsd of ≥18 cm above the phantom. The observed surface dose 
increased by about 5% and the difference was close to zero for small field sizes of less or 
equal to 5x5 cm2. The transmission coefficient of the MP512T measured at dmax is close 
to 1.00 at Dsd of ≥18 cm, and with a deviation of about 1.010-1.020 when decreasing Dsd 
below 18 cm. 
The measurement setup is shown in Figure 6.1. The MP512T was connected to a Data 
Acquisition System (DAQ) designed and built at CMRP. The system is based on a 
multichannel electrometer chip. The DAQ consists of a Field Programmable Gate Array 
(FPGA) that is read out in parallel by four analogue-to-digital converters (ADC). The 
FPGA provides the clock and synchronization circuit for the DAQ allowing its 
synchronization with the sync signal of the Linac. This guarantees that the charge 
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generated in the detector is only acquired when the electron gun fires, avoiding any loss 
of signal or unnecessary integration of dark current or electromagnetic induced noise. For 
further details regarding the DAQ, refer to Fuduli et al.[201].  
 
 
(a) 
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(b) 
 
Figure 6.1. (a) TM measurement setup of the MP512T allowing various distances 
between the Linac head and solid water phantom surface, (b) DM measurement setup of 
MP512T at a depth of dmax. 
 
All experiments were performed on a Varian (Model 21XI) accelerator using 6 MV 
photon beams. Since the MP512T has a thickness of 0.45 mm it is, therefore, possible to 
operate it in both transmission mode and dose mode. The TM responses were measured 
by placing the MP512T on the movable stand holder positioned at various Dsd ranging 
from 0.3 cm to 24 cm. The MP512T was covered with a black plastic sheet, 80 µm thick 
making the detector more light tight.  
For the DM response, the MP512T was positioned in a homogenous solid water phantom 
at depth of dmax (1.5 cm for 6 MV). As discussed in chapter 4, the air gap above the detector 
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was set to 0.5mm so that electronic equilibrium is fully established for measurements of 
output factors and PDD (within ±2%) [242], [243].  
The TM and DM response measurements were performed for field sizes of 2 x 2 cm2,  
3 x 3 cm2, 5 x 5 cm2, 8 x 8 cm2 and 10 x 10 cm2, and the treatment field size was defined 
at a source to surface distance (SSD) of 100 cm. Each measurement was obtained 
delivering 200 MU. All measurements were repeated in triplicate, and the resulting 
standard error was calculated. To find the correlation between DM and TM measurements 
the ratio of DM and TM, measurements were evaluated for each experimental setup. 
 
6.2.2 Dose calculation for regular fields 
 
The TM response was measured for regular field sizes of 1 x 1 cm2 and 4 x 4 cm2 at a Dsd 
of 4 cm and 24 cm. The DM response at dmax was then calculated using the DM/TM 
correlation shown in Equation 6.1. Note that these field sizes were not part of the 
measurement set used to obtain the correlation. The field size of 1 x 1 cm2 lies outside the 
measurement set and the expected response DM was extrapolated. While the 4x4 cm2 field 
size lies between 2 of the field sizes of the measurement set and interpolation was used to 
determine the expected DM response. The calculated doses were compared with the 
measured dose determined using the MP512T detector placed in solid water at dmax. 
6.2.3 Dose calculation in IMRT fields 
 
To determine the delivered dose at dmax from MP512T transmission measurements, 
intensity modulated fields used to treat a malignant base of skull chordoma were delivered 
with the TM in place. The plan consists of 6 static fields and delivering a nominal dose 
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1.8 Gy per fraction to the target volume (12.40 cm3). All IMRT fields were delivered with 
the gantry set to 0° (gantry pointing vertically downward toward the phantom surface) for 
a Dsd of 4 and 24 cm. A gamma evaluation with criteria of 1%/1mm, 2%/2mm and 
3%/3mm was used to compare the measured dose distribution at dmax predicted from 
transmission measurements to the dose computed at dmax using the TPS and the dose 
measured by EBT film.  
 
6.3 Results 
6.3.1 The ratio of DM and TM response 
 
The ratio of the DM to TM response for the central pixel of the MP512T at various Dsd 
and field sizes is shown in Figure 6.2. The ratio of the DM to TM response for off-central 
pixel including; -4mm, 4mm, -8mm, 8mm, -10mm, 10mm, -14mm and 14mm is shown 
in Figure 6.3, Figure 6.4, Figure 6.5, Figure 6.6, Figure 6.7, Figure 6.8, Figure 6.9, and 
Figure 6.10 respectively. 
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Figure 6.2. The ratio of DM and TM response at central pixel measured by MP512T at 
dmax for different Dsd, with constant irradiation field sizes. 
 
 
Figure 6.3. The ratio of DM and TM response at -4mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
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Figure 6.4. The ratio of DM and TM response at 4mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
 
Figure 6.5. The ratio of DM and TM response at -8mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
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Figure 6.6. The ratio of DM and TM response at 8mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
 
Figure 6.7.The ratio of DM and TM response at -10mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
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Figure 6.8. The ratio of DM and TM response at 10mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
 
Figure 6.9.The ratio of DM and TM response at -14mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
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Figure 6.10. The ratio of DM and TM response at 14mm off-central pixel measured by 
MP512T at dmax for different Dsd, with constant irradiation field sizes. 
 
The measurements points for each field size were fitted with a trend line using the least 
squares method. Table 6.1 shows the resulting slope (M) and the DM/TM axis intercept 
(BA0) for the central pixel of the MP512T at dmax for all field sizes. The uncertainty of the 
calculated slope was within 0.21% (1SD) and 0.18% (1SD) for the intercept. 
 
Table 6.1. Slope (M) and DM/TM axis intercept (BA0) at dmax for the central pixel of the 
MP512T for various field sizes 
Parameter 
Field Size (cm2) 
2 3 5 8 10 
M 0.0199 0.0210 0.0180 0.0191 0.0201 
BA0 1.1649 1.1437 1.0281 0.9686 0.9530 
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From the results, the ratio of off-center pixels shows a similar behaviour to that of the 
central pixel. The average difference between the central pixel slope and off-center pixel 
slope was within ±1.79% (1 standard deviation). 
 
6.3.2 The DM and TM correlation  
 
As can be seen from Table 1, the slope M of the trend lines for DM /TM versus Dsd only 
weakly depends on the field size, and hence we have chosen to work with an average value 
of the slope M. However, the same is not true for DM/TM axis intercept. Using an average 
value, the slope M and the specific values for the DM/TM axis intercept in Table 1, one 
can predict the dose at dmax using a transmission measurement as follows:  
 
𝐷𝑀 = (𝑇𝑀)𝐷𝑠𝑑(𝐵𝐴0 − 𝑀𝐷𝑠𝑑)…………………………… (6.1) 
 
Here M is the average slope for all field sizes, which was found to be 0.01960. DM/TM 
axis intercept BA0 for an arbitrary equivalent field size as a function of the field area can 
be found from the piecewise polynomial fit to the data shown in Figure 6.11. 
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Figure 6.11. The relation of the DM/TM axis intercepts (BA0) as a function of field area 
(A). 
 
This data is well described by the following piecewise polynomial fits with each fit having 
an R2 value of 1: 
 
B
Ao
=
-0.00014214286 × A2  -  0.00239214286 × A+  1.17674285714  for   0 cm2  ≤  A ≤   25 cm2
0.00001456410 × A2  -  0.00282184615× A +  1.08954358974  for  25 cm2  <  A ≤ 100 cm2
ì
í
ï
îï
(6.2) 
The “kink behaviour” on Fig 6.11 is possibly due to the fact that all measurements were 
related to Dmax depth 15 mm that is actually Dmax for 10cmx10cm field only. Further 
investigation will be carried out for obtaining relation (6.1) for true Dmax for all filed sizes, 
however it is outside of this thesis 
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6.3.3 Dose calculation for regular fields 
 
For regular field size dose calculation, the responses at dmax were calculated when the TM 
responses were measured at the detector to surface distances of 4 and 24 cm. The DM/TM 
axis intercept BA0 for the 1x1cm
2 and 4x4cm2 field size were obtained from  
 
Equation 6.2. Note that the BA0 value for the 1x1cm
2 field size results from extrapolation 
while that for the 4 x 4 cm2 field size is obtained by interpolation as shown in Table 6.2. 
 
Table 6.2. The calculated BA0 for field size (A) 1x1 cm
2 and 4x4 cm2. 
A (cm2) BA0 
1 1.2300 
4 1.0900 
 
The detector responses were multiplied by the calibration factor to convert the measured 
detector signal to the absorbed dose (Gy). The dose calculation for regular fields is shown 
in Table 6.3. For field size 1x1 cm2 the difference between measured dose and calculated 
dose was -2.18% at 4cm Dsd and 0.63% and 24 cm Dsd. For field size 4x4 cm
2 the 
difference between measured dose and calculated dose was 0.93% at 4cm Dsd and 1.95% 
and 24 cm Dsd.  
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Table 6.3. The measured and calculated dose response of MP512 for central pixel at dmax 
for field size 1x1 cm2 and 4x4 cm2 
Dsd 
(cm) 
Dose response of MP512 at dmax (Gy) 
Field Size 1x1 cm2 Field Size 4x4 cm2 
Measured Calculated % Diff Measured Calculated % Diff 
4 0.8157 0.7979 -2.18 1.0040 1.0133 0.93 
24 0.8157 0.8208 0.63 1.0040 1.0195 1.95 
 
The absorbed dose for the 1x1cm2 field size was also compared with the dose measured 
by EBT3, the difference being within ±1.73% for both detectors to surface distances. 
 
6.2.4 Dose calculation for IMRT fields 
 
For the IMRT dose calculation, the measurement and calculation were evaluated only at 
the central fragment of the plan since the active MP512T detector area is 5.2 x 5.2 cm2. 
The plan consists of 6 delivery gantry angles. The equivalent field size (Aeq) for each 
gantry angle was calculated using the standard equivalent square relationship shown in 
equation (6.3) [244].  
 
 𝐴𝑒𝑞 =
2𝑥𝑦
𝑥+𝑦
   …………………………………. (6.3) 
 
DM/TM axis intercepts, BA0, for any square field were obtained from the second order 
polynomial fits shown in Equation 6.2. Table 6.4 shows the equivalent field for each 
gantry angle and the calculated BA0. 
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Table 6.4.  The equivalent field (Aeq) for each angle and the calculated BA0 
Gantry (°) Field Size (cm2) 
Equivalent Field 
size (cm2) 
BA0 
150 5x7.5 6x6 1.0068 
100 5x7.5 6x6 1.0068 
60 5x6 5.45x5.45 1.0186 
300 5x7.5 6x6 1.0068 
260 5x5.5 5.23x5.23 1.0233 
210 5x5.5 5.23x5.23 1.0233 
 
All calculated planar doses for each gantry at dmax were accumulated and compared with 
the planar dose extracted from the TPS, the planar dose measured by EBT3 film and the 
measured dose measured by MP512T at dmax by using Matlab. 
Figure 6.12 shows the example the MP512T calculated planar dose at dmax from MP512T 
transmission measurement Dsd = 4 cm compared to the dose from TPS with the gamma 
evaluation of 3%/3mm using Matlab. All gamma evaluation is shown in Table 6.5. The 
script used for gamma evaluation is in appendix B. 
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Figure 6.12.The comparison of MP dose calculated when placing MP512T at Dsd = 4 cm 
with the planer dose from TPS. 
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Table 6.5. The gamma evaluation for IMRT plan dose calculation at Dsd of 4 and 24 cm 
Dsd 
(cm) 
Gamma Evaluation 
3%/3mm 2%/2mm 1%/1mm 
MPcal-
TPS 
MPcal-
EBT3 
MPcal-
MPmeasured 
MPcal-
TPS 
MPcal-
EBT3 
MPcal-
MPmeasured 
MPcal-
TPS 
MPcal-
EBT3 
MPcal-
MPmeasured 
4 98.14% 96.89% 99.79% 90.50% 92.00% 98.59% 62.20 69.40 99.40 
24 97.22% 97.53% 99.69% 93.80% 93.80% 97.69% 59.00 71.00 99.00 
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6.4 Discussion 
 
In this chapter it was demonstrated that by placing the monolithic pixelated silicon 
detector, MP512T at different positions between the Linac head and the solid water 
phantom surface, a variable effective spatial resolution is provided. This allows one to 
probe small radiation fields intersecting the detector at different spatial resolutions. In 
particular, a functional relationship between the dose in phantom, DM, and the 
transmission dose, TM, as a function of detector to surface distance (Dsd) was derived. 
The Dsd values were varied from 0.3 cm to 24 cm and the area of the radiation field that 
can be used to derive the dose in phantom for arbitrary radiation fields was found to be 
based on the transmission dose measurements. The calculated IMRT planar dose at dmax 
illustrated good agreement when compared with dose predicted by the TPS and measured 
using EBT3 film. The poor pass rate for the gamma criteria of 1%/1mm can be explained 
by possible submillimeter misalignment of registration of the film in the MP512T frame 
of reference in TM and for the case of the TPS, by the voxel size in the dose calculation 
which is larger than 1mm3. The registration of the same MP512T in the DM coordinate 
system relative to the MP512T in TM is more accurate however. In addition, both 
detectors have a pixel size of 0.5x0.5 mm2, which is less than 1x1 mm2. The obtained 
result confirms that the MP512T can provide dose mapping at dmax with a spatial 
resolution of order 1 mm and this is important for a small treatment fields such as those 
used in SRS. 
Since SRS and SBRT employ small radiation fields to conform the radiation dose tightly 
to the target, meaningful treatment verification requires QA tools having a high spatial 
resolution that accurately provide relevant dose information. The MP512T employed in 
this work as a transmission detector has the potential to be used for real-time dose 
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monitoring of small radiation fields, opening the door to real time 3D dose verification, 
based on transmission measurements as the treatment is being delivered to the patient. 
Hence, this work represents the first step in the development of real-time 3D dose 
reconstruction based on TM measurements. 
Note that the effective measurement area of measurement (Ao) at dmax can be 
obtained from the sensitive area ATM of the MP512T as a function of Dsd as follows, cf. 
Equation 6.4. 
𝐴0 = 𝐴𝑇𝑀 (
𝐿+1.5 
𝐿−D𝑠𝑑
)
2
……………………………………… (6.4) 
Where, L is a source to surface distance, which for conventional linear accelerators is 100 
cm. 
 
6.5 Conclusions 
 
The work described in his chapter demonstrates that the dose in a phantom can, in 
principle, be calculated at any depth of interest based on the transmission measurements 
made with the MP512T detector. The calculated dose for regular field sizes and intensity 
modulated fields for a clinical case have shown good agreement when compared with the 
dose predicted by the TPS and measured using EBT3 film. This study demonstrates the 
potential of our pixelated monolithic silicon detector as a transmission detector that can 
be used for small field QA, and that has the potential to be used for real-time 3D dose 
reconstruction as therapy is delivered.  
 
  
 
 
 
CHAPTER 7  
CONCLUSION AND FUTURE WORK 
 
Radiation therapy has become one of the main treatment options for cancer over the last 
several decades with over 50% of patients having some form of radiation therapy as part 
of their cancer management plan. There is a contribution to modern radiotherapy 
techniques, such as IMRT, VMAT and SRS/SBRT. These sophisticated treatment 
techniques enable the high-energy X-ray beam to be adjusted, changing the beam shape 
and intensity to conform better to the shape of the tumours while sparing the radiation 
dose to the normal healthy tissue. The concentrated radiation dose techniques use many 
multileaf collimators that can move independently in the beam path in order to block the 
beam and generate the high precision in millimetre sized radiation dose voxels.  
The movement of the leaves is controlled and optimized by the calculation algorithm from 
the treatment planning system. There are more parameters that the system uses for 
computing the expected dose distribution in the patient such as beam energy, delivery 
time, type of tissue in the beam line, etc. To check if all parameters for this complex plan 
are correct, sophisticated treatment planning verification is needed. The verification 
method ensures the treatment plan delivers the radiation dose so as to match well to the 
dose delivered to the patient. 
Online treatment verification is needed during the treatment delivery. Using such a 
method, any errors can be detected in real-time, and the treatment can be stopped 
immediately and re-planned to accommodate for the error. The additional software and 
hardware that are required for this decision are not related to the work presented this 
thesis. 
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The CMRP at UOW has developed a 2D monolithic silicon diode detector array known 
as “Magic Plate512” for in-phantom dosimetry and transmission measurements with 
millimetre spatial resolution that is variable. 
In this thesis, in-phantom dosimetry has been studied. The effect of the air gap size above 
the detector was investigated and its impact on the measured output factor, wedge beam 
profile and percentage depth dose for both photon and electron beams. In this study, the 
suitable air gap was optimized for each beam energy utilized.  
The output factor measured with the MP512 reduced with the increase of the detector air 
gap at the smaller radiation field size. The MP512, with the air gap of 0.5 mm and 1.2 
mm, show good agreement to the output factors measured with the EBT3 film and 
MOSkin within ±2% for 6 MV photon beam fields and 10 MV, respectively.  
The optimal air gap size for 6 MV and 10 MV energy was confirmed through similar 
results for the expected PDD measurement. The PDD measured by MP512 with a 0.5 mm 
(for 6 MV) and 1.2 mm (for 10MV) air gap size was within ±3% of the EBT3 for the 2 x 
2 cm2 field for both photon energies. For the larger fields such as 5x5 cm2, and 10x10 
cm2, the PDD measured with the MP512 is within ±1.6% and ±1.5% of that measured 
using a Markus IC for 6 and 10 MV fields respectively.  
The thesis used the optimal air gap size of 0.5 mm for 6 MV and 1.2 mm for 10 MV for 
wedge beam profile measurements. As expected, the difference between the beams 
profile measured by the MP512 and EBT3 film increases with increasing the air gap size. 
The air gap causes a measurable dose reduction for small radiation fields due to the loss 
of electronic equilibrium.  
The thesis also investigated the effect of the air gap size above the MP512 detector for 
various energies of electron beams. However, the effect on electron beam is not 
significant due to an electronic equilibrium being fully established and maintained. 
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The MP512, with a different detector packaging incorporated into the design was called 
MP512T. The detector is 0.45 mm thick and was then used as a transmission type 
detector. This thesis came up with, and demonstrated, the idea of the adjustable effective 
detector spatial resolution by placing the MP512T on a movable stand and moving the 
detector in the direction between the target in the patient and the Linac head.  
By moving the detector between the patient and the Linac head it is possible to change 
the effective spatial resolution for dosimetry in a monitored radiation field. These 
detectors allow us to obtain a variable effective spatial resolution from 2 mm to 4 mm for 
the MP512T detector. For a small tumour size, placement of the detector closer to the 
patient will improve the spatial resolution in transmission mode, while monitoring of the 
whole radiation field is still possible. 
In this thesis, the influence of the MP512 on the beam was studied. In particular any 
perturbation measured as a change in the surface dose and beam transmission factors were 
investigated when operating the MP512T in transmission mode and with the MP512T 
placed at various distances from the solid water phantom. 
When placing the detector at the distance of above 18 cm above the phantom surface 
produced only a small perturbation of the surface dose, measured as an increase in surface 
dose by less than 5%. The increase in surface dose was negligible for radiation field sizes 
of 5 x 5 cm2. The difference in surface dose between MP512T faced up and faced down 
showed only a 2% difference. The effect of the PCB without the detector mounted on the 
surface also indicated that at the distance of more than 18 cm, the percentage difference 
is close to zero for all irradiated field sizes. The PCB alone increased the surface dose by 
about 60% compared to the increase in the surface dose from the MP512T. Due to the 
Compton Effect electrons are mostly created at the MeV range, and this suggests that an 
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opening or recess in the PCB under the active area of the silicon monolithic detector is 
recommended to reduce the increase in skin dose for all the considered IFSs. 
The measurement of transmission coefficient of the MP512T detector at dmax is close to 
1 as the distance between the MP512T detector and the phantom surface decreased below 
18 cm. The PCB under the silicon monolithic detector makes the transmission coefficient 
closer to 1 for any placement of the proposed transmission detectors between patient and 
the Linac head. 
In this thesis, the use of the MP512T as a transmission-type detector was studied in more 
detail with an example of a real clinical scenario.  The correlation of the transmission 
mode response (TM) and dose mode response (DM) of the MP512T for different detector 
to surface distances (Dsd) and treatment field sizes were used to predict the dose at dmax.  
The optimal air gap size above the detector for 6MV photon beam (0.5 mm) was applied 
for the dose mode measurement of MP512 at dmax. For TM, the MP512T was positioned 
at various values of Dsd. The results showed that a correlation between TM and DM 
existed and could be employed to predict the dose at dmax.  
When placing the MP512T at a Dsd of 4 cm and 24 cm, the predicted dose for a regular 
field size of 1x1 cm2 fell within 2.18% compared to the measured dose. The predicted 
dose when placing the MP512T at the same Dsd for 4 x 4 cm
2 fell within 1.95% of the 
measured dose. 
The performance of the MP512T when used to calculate the dose for the clinical IMRT 
plan was in good agreement with the TPS and the EBT3 film. The gamma criterion of 
3%/3mm pass rate was 98.14% for Dsd 4 cm and 90.5% for Dsd 24 cm. The pass rate of 
2%/2mm was 97.22% for Dsd 4 cm and 93.8% for Dsd 24 cm.  
Future work will be to develop the real-time high spatial resolution 3D dose 
reconstruction algorithm based on the TM measurements using the MP512T. Moreover, 
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the mechanical realization of proposed transmission detector will be realized on a 
telescopic jig attached to the Linac head block tray slot together with a wireless reader 
developed at CMRP. 
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Appendix A  
Solid works drawing 
 
The detector holder with specific geometries were designed for particular part of this 
thesis. A 3D drawing was generated by using Solid works (Das-sault Systems SolidWorks 
Corporation, Massachusetts, USA) 
 
A.1 The transmission Magic Plate 512 (MP512T) detector holder 
 
The special holder shows in Figure A.1 was used for the work descripted in Chapter 5 
and Chapter 6. 
 
 
 
Figure A.1: The transmission Magic Plate (MP512T) detector holder 
 
Appendix A: Solid works drawing
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A.2 The movable stand detector holder 
 
The movable sand detector holder shows in Figure A.2 was used in the work described in 
Chapter 5 and Chapter 6. 
 
 
 
Figure A.2: The movable stand detector holder 
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Appendix B  
Matlab Scripts 
 
Matlab script was designed by using Matlab (The MATHWORK Inc.) to manage the data 
involved in the thesis. 
B.1 EBT3 Film Center Location 
 
This script was used to find the center of the EBT3 film. 
 
function [x0,y0] = center(A) 
if size(A,3)== 3 
A = double(rgb2gray(A)); %Do image to gray scale 
end 
 [row,col] = size(A);  % Find the size of the image 
%% Determine location * image value 
Mx = ones(row,1)*(1:col).*A;  
My = (1:row)'*ones(1,col).*A; 
%% Determine the total value summation 
area = sum(A(:)); 
% check for zero values 
if area == 0 % central mass on uniform image 
x = row/2; 
y = col/2; 
else 
% Calculate centroids 
x = sum(Mx(:))/area;% centroid location of x 
y = sum(My(:))/area;% centroid location of y 
end 
if nargin==2 && pix 
x = round(x); %x is the center of coll 
y = round(y); %y is the center of raw 
end 
 
% Make in the integer number 
 
y0=round(x); %switch to X axis when x is a position of column 
 
x0=round(y); %switch to Y axis when y is a position of row 
end 
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B.2 MP512 Pixel Interpolation 
 
There was some dead pixel during the measurement by MP512. This script was used to 
interpolate between the functional detector pixel and the dead one.  
 
 
function [ newdata ] = InterpolateHelper( data ) 
warning('off','all') 
warning 
    newdata = zeros(24,24); 
    [n_rows, n_columns] = size(data); 
     
    newdata(1,:) = data(1,:); 
    newdata(:,1) = data(:,1); 
    newdata(24,:) = data(24,:); 
    newdata(:,24) = data(:,24); 
     
    fprintf('Start row pass'); 
    %row pass 
    for n=2:n_rows-1 
        check = 1; 
        while(check) 
           fprintf('Start rows %d\n', n); 
           focus = data(n,:); 
           line = [1:24]; 
           [fitresult, gof] = createFit(line, focus); 
           prompt = 'How many pixels do you want to interpolate:'; 
           n_pixels = input(prompt); 
           if n_pixels > 0 
               fix_pixels = []; 
               for n_pixel=1:n_pixels 
                   fprintf('What is the pixel No. %d that you want to 
fix',n_pixel); 
                   promt = ':'; 
                   fixing_pixel = input(promt); 
                   fix_pixels(n_pixel) = fixing_pixel; 
               end 
  
                [fitResult, gof ] = createFit2(line, focus, 
fix_pixels); 
                for n_pixel = 1:n_pixels 
                    pixel = fix_pixels(n_pixel); 
                    focus(fix_pixels) = fitResult(fix_pixels); 
                end 
           end 
            createFit(line, focus); 
                newdata(n,:) = focus; 
                prompt = '0 = ok, 1 = redo'; 
                check = input(prompt); 
            close all; 
        end 
    end 
     
     
    fprintf('Start column pass'); 
    % column pass 
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    for n=2:n_columns-1 
        check = 1; 
       while(check)  
           fprintf('Start column %d\n', n); 
           focus = newdata(:,n); 
           line = [1:24]; 
           [fitresult, gof] = createFit(line, focus); 
           prompt = 'How many pixels do you want to interpolate:'; 
           n_pixels = input(prompt); 
           fix_pixels = []; 
           if n_pixels > 0 
               for n_pixel=1:n_pixels 
                   fprintf('What is the pixel No. %d that you want to 
fix',n_pixel); 
                   promt = ':'; 
                   fixing_pixel = input(promt); 
                   fix_pixels(n_pixel) = fixing_pixel; 
               end 
  
                [fitResult, gof ] = createFit2(line, focus, 
fix_pixels); 
                for n_pixel = 1:n_pixels 
                    pixel = fix_pixels(n_pixel); 
                    focus(fix_pixels) = fitResult(fix_pixels); 
                end 
           end 
           createFit(line, focus); 
           newdata(:,n) = focus; 
           prompt = '0 = ok, 1 = redo'; 
           check = input(prompt); 
           close all; 
       end 
    end  
end 
  
 
B.3 Gamma Evaluation 
 
This script is used for calculated the gamma evaluation described in chapter 6. 
 
function [GammaMap numpass avg numWithinField] = GammaCompare(Image1, 
Image2,x_size,y_size,EPIDppx, Dose_tol, DTA_tol, FE_thresh, rad, 
varargin) 
% Compare Image2 to reference image (TPS) Image1 
% rad: radius - in points - need to work out before pass  
% GAMMA settings 
% x_size = image x size  
% y_size = image y size  
% Dose_tol = DoseTol; % Percent of maximum dose. Given as a fraction 
% DTA_tol = DistTol; % cm 
% FE_thresh = ThreshFx;  % Given as a fraction 
% rad = radius; distance in cm to search 
% Note: DTA tolerance and specified X, Y points must be in the same 
units 
  
% example  
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% [GammaMap numpass avg numWithinField] = GammaCompare(img1, im2, 
1024, 768,0.0392, 0.03, 0.3, 0.1,5); 
  
  
debuglevel = 0; 
% EPID pixel size spacing (EPIDppx) = 0.0392 (1024X768); =0.0784 
(512X384) 
% - AS1000 EPID 
xp = (1:x_size)*EPIDppx; 
yp = (1:y_size)*EPIDppx; 
res_x = xp(2) - xp(1); 
res_y = yp(2) - yp(1); 
  
% if radius not specified, compute a sensible one 
% Expand DTA tolerance by 50%. Use this as a search radius 
if ~exist('rad','var') || isempty(rad) 
    radlim = DTA_tol * 1.5; 
    rad = min(ceil(radlim/res_x),ceil(radlim/res_y)); 
end 
 
MaxVal = max(Image1(:)); 
Mask = zeros(size(Image1)); 
crit_val = FE_thresh*MaxVal; 
  
% Use the Resampled image for this - EPID no spikes? 
Mask(Image1>crit_val) = 1; 
  
Dose_tol = Dose_tol*MaxVal; % GLOBAL - PERCENTAGE OF MAX DOSE 
if debuglevel > 1 
    fprintf('Maximum dose for Gamma: %2.1f cGy\n',MaxVal); 
    fprintf('Dose Tolerance for Gamma: %2.1f cGy\n',Dose_tol); 
    fprintf('DTA: %2.1f\n', DTA_tol); 
    fprintf('FE_thresh: %2.1f\n', FE_thresh); 
    fprintf('rad: %2.1f\n', rad); 
    fprintf('Image 1 val: %2.1f\n',Image1(round(size(Image1,1)/2), 
round(size(Image1,2)/2))); 
    fprintf('\n'); 
end 
  
% VECTORIZED CALCULATION STARTS HERE 
  
% GammaMapsub will carry the calculated gamma values for the truncated 
% images. GammaMap2 will be the Gamma values for the full image. 
GammaMapsub = NaN; 
GammaMap = zeros(size(Image1)); 
% Find the threshold limits for truncation 
[validmask_y validmask_x] = find(Mask); 
min_x = min(validmask_x)-rad; 
max_x = max(validmask_x)+rad; 
min_y = min(validmask_y)-rad; 
max_y = max(validmask_y)+rad; 
if min_x < 1 
    min_x = 1; 
end 
if min_y < 1 
    min_y = 1; 
end 
if max_x > size(Image1,2) 
    max_x = size(Image1,2); 
end 
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if max_y > size(Image1,1) 
    max_y = size(Image1,1); 
end 
% Truncate the images to avoid needless calculations 
Im1 = Image1(min_y:max_y,min_x:max_x); 
Im2 = Image2(min_y:max_y,min_x:max_x); 
% Shift the image by varying amounts. Determine the minimum gamma 
value 
% for all shifts 
for i=-rad:rad 
    for j=-rad:rad 
        % circshift function wraps elements from top to bottom as 
necessary 
        % The entire image is shifted at once 
        Im2_shift = circshift(Im2,[i j]); 
        dist = sqrt((res_y*i)^2 + (res_x*j)^2); 
        DoseDiff = Im2_shift - Im1; 
        % Compute the gamma map for this particular shift value 
        Gamma_temp = sqrt((dist./DTA_tol).^2 + 
(DoseDiff./Dose_tol).^2); 
        % Accumulate the map of the minimum values of gamma at each 
point 
        GammaMapsub = min(GammaMapsub,Gamma_temp); 
    end 
end 
% Put the truncated gamma map back into its proper location within the 
full 
% gamma map 
GammaMap(min_y:max_y,min_x:max_x) = GammaMapsub; 
% Remove any edge effects from the circular shifting by multiplying by 
the 
% mask values. This will negate any calculated gamma values around the 
% edges of the distribution where this effect would arise 
GammaMap = GammaMap .* Mask; 
% Ensure that NaN values outside the mask do not affect the 
calculation 
GammaMap(~Mask) = 0.0; 
  
% Compute statistics 
numWithinField = nnz(Mask); 
numpass = nnz(GammaMap<1 & Mask)./numWithinField; 
avg = sum(GammaMap(:))./numWithinField; 
 
 
